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“In the middle of difficulty, lies opportunity” 
 Albert Einstein (1879 – 1955)  
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1. Synopsis: 
 
 
There is evidence that many diseases are not only determined by gene alterations. A clear example is cancer, 
encompassing several complex diseases where both genetic and non-genetic factors interact over the lifespan; the 
latter including environment exposures and the microbiome that can be assessed using omics approaches. Omics is a 
recent area of study including several biological disciplines. The technologies applied to omic sciences allow the study, 
at a molecular level, of the different elements that make up biological systems. Recently, biomedical science focusses 
on a new area: microbiome, where various associations between certain microorganisms and diseases have been found. 
One of the challenges in modelling cancer risk is the analysis of microbiome data: microbe counts are sparse and the 
data are high dimension and contain a large proportion of zeros. 
This project aims to show different alternatives for the analysis of counting data that are characterized by a clear over-
dispersion and excess of zeros. Moving ahead from classical linear models, there are regression models, such as Zero 
Inflated models or "Hurdle" models, I was able to establish what kind of zeros are in the database. These models and 
their corresponding distributions are subjected to different selection criteria with the purpose of establishing which is 
the model that best fits the data, depending on the percentage of zeros that it presents. By applying these approaches, 
I could appropriately define relationships between different microorganisms and gene expressions, tumour stages, 
immune subtypes, gender, BMI, ...   
Keywords: microbiome, overdispersion, zeros, regression models, Hurdle models. 
 
 
Existen evidencias de que muchas enfermedades no están determinadas sólo por alteraciones genéticas. Un claro 
ejemplo es el cáncer que engloba muchas enfermedades producidas por la interacción de factores genéticos y no-
genéticos durante toda la vida. Entre los factores no-genéticos se encuentran la forma en que los seres humanos viven 
e interactúan con el medio ambiente y el microbioma; ambas exposiciones pueden ser caracterizadas con datos ómicos. 
Las tecnologías ómicas representan una reciente área de estudio que engloba diversas disciplinas biológicas. Las 
tecnologías aplicadas a las ómicas permiten estudiar, a nivel molecular los diferentes elementos que componen los 
sistemas biológicos. Hoy en día, el foco se encuentra en una nueva área: la microbioma, puesto que se han encontrado 
diversas asociaciones entre ciertos microorganismos y enfermedades. El reto principal en el análisis de datos de 
microbioma es el escaso número en los datos de conteo de microbioma, los cuales son de gran dimensión y contienen 
una gran proporción de ceros.  
En este proyecto se pretende mostrar diferentes alternativas para el análisis de datos de conteo que se caracterizan por 
una clara sobredispersión y exceso de ceros. Aplicando modelos de regresión como los modelos de inflación de cero 
o los modelos Hurdle pude establecer qué tipo de ceros se encuentran en la base de datos. Estos modelos y sus 
correspondientes distribuciones están sometidos a diferentes criterios de selección con el objetivo de establecer cuál 
es el modelo que mejor se ajuste a los datos en función del porcentaje de ceros que presente. Ello me ha permitido 
definir relaciones entre diferentes microorganismos y expresiones genéticas, estadios tumorales, subtipos inmunes, 
género, IMC, ...   
Palabras clave: microbioma, sobredispersión, ceros, modelos de regresión, modelos Hurdle. 
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2. Introduction to Omics Data: 
 
Omics is comparatively new space of study that cut across the biological disciplines and has 
relevancy to all biological sciences. It attempts to look at biological systems in a holistic way and 
to account for all interactions between genes, proteins, RNA and metabolites (Arivaradarajan & 
Misra, 2019). From the second half of the XX century, and mainly at the end of it, technologies 
based on the progress of molecular biology were developed. In their development, these 
technologies were grouped around what is known globally today as the “omics sciences” and 
which refer to the knowledge derived from the application of a set of technologies that make 
possible the study at a molecular level of the different elements that make up biological systems 
in all their complexity, including the result of the interactions and relationships that occur between 
the internal components of the individual and the external elements. The technologies used by 
omics, called "omic technologies", are mainly characterized by generating massive amounts of 
data (also called big data) in a single experiment from a single sample.  
It was as a result of the Human Genome Project in 1990 that genomics emerged as the first "omics" 
to be studied, which was based on the study of the genome or DNA. At the beginning of the XXI 
century the sequence of the human genome was reported (Venter et al., 2001), the order of all the 
nucleotides contained in the human DNA was deciphered (International Human Genome 
Sequencing Consortium, 2004). Although genomics offers correlations between diseases and gene 
variants, it does not demonstrate how that variable can be a cause of the disease. Therefore, it is 
necessary to integrate these correlations with other "omics" to find the function of genes and the 
variants that modulate them, in order to better understand the cause of a certain disease. 
Thanks to the central dogma of biology, it is known that DNA is transcribed into messenger RNA 
(mRNA), which is also known as transcript (Figure 1). Transcriptomics is the "omics" that studies 
the expression of transcripts coming from different genes. The mRNA is specific to each cell and 
to the pathophysiological conditions at a given time; thanks to the methodologies used to analyze 
the mRNA, comparisons can be made between cases and/or controls, or to check which genes are 
expressed under certain conditions. Currently, one of the applications of transcriptomics is the 
analysis of the expression of genes involved in different types of cancers. (Unger‐Saldaña et al., 
2015). The mRNA is translated into proteins, which are made up of aminoacids, which are 
responsible for performing the corresponding function of the gene. Proteomics studies thousands 
of proteins present in a sample. Once the proteins are translated, they can undergo post-
translational modifications, these modifications cause structural changes that control the formation 
of functional protein complexes: they regulate the activity of the proteins and transform them into 
active or inactive forms. The Human Proteome Project has provided a list of proteins that have 
been found in different cell types and organs from different people. This data is public and reports 
more than 30,000 identified proteins in humans (Omenn et al., 2015). 
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Metabolites are those molecules that participate as substrates, intermediaries or products in the 
chemical reactions of metabolism; it is defined as a technology for determining the overall changes 
in concentration of metabolites present in a fluid, tissue or organism in response to a genetic 
variation, physiological or pathological stimulus (Cambiaghi et al., 2017). Metabolomics allows 
us to analyze the metabolic profile of a sample, both quantitatively and qualitatively.  
In recent decades it has been shown that DNA can fold into three-dimensional structures that can 
regulate distant regions. Therefore, the sequence of nucleotides, then, is not the only thing that 
regulates gene expression, but how "tangled" the DNA is and its positioning during the formation 
of complex structures, that make up chromosomes. Epigenetics refers to the set of processes by 
which gene transcription is regulated without affecting the DNA sequence, this science represents 
the overall epigenetic changes in a sample, at a given time and under specific pathophysiological 
conditions. 
There are as many omics sciences as biological or molecular elements that can be studied by these 
technologies, not only are sciences such as proteomic, transcriptomic or genomic taken into 
account; the list has been extended in recent decades, and there are currently research groups 
focused on these new areas of knowledge, which in the future will be considered as "emerging" 
omics field, including nutrigenomics, exposomics, lipidomics or metagenomics. 
 
Figure 1. The central dogma of molecular biology and its relationship to the omics sciences: the genetic information contained 
in the DNA is transcribed into messenger RNA (mRNA) and non-coding RNA. The mRNA gives rise to proteins, through a 
process called translation. Proteins carry out the cellular functions, through which they generate or consume different 
metabolites. These metabolites and proteins, together with non-coding RNA, are involved in the regulation of these processes, 
forming a highly complex system of interactions. In this scheme, we summarize graphically what molecular aspect each of the 
"established" omics field encompasses in relation to the internal elements of the individual. Image created with Biorender.com.  
All these omics have a crucial role in the health sciences: they help to search for biological markers 
of diagnosis and prognosis of diseases, discover therapeutic targets against which new drugs could 
be developed, determine which molecular mechanisms are involved in the pathogenesis of 
diseases, among others. The amount of information obtained with these techniques is such that it 
exceeds human discernment, which is why powerful statistical and computer techniques are 
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needed to interpret the data obtained; bioinformatics and biostatistics become essential tools 
behind the development of any omics and necessary for the management of them. 
Today the focus is on one of these "emerging" omics, metagenomics, where various associations 
between certain microorganisms and diseases are being found. In recent years, taking the Human 
Genome Project as a base, several projects related to this field have been developed, the Human 
Microbiome Project (USA) (Turnbaugh et al., 2007), (Hutchison, 2007), and the European Project 
MetaHIT (MetaHIT Consortium -Metagenomics of the Human Intestinal Tract Consortium- 
Wellcome Sanger Institute), with Spanish contribution. The latter was selected by the prestigious 
scientific journal Science as one of the 10 most notable discoveries of 2011. Both are responsible 
for studying the microorganisms that inhabit our bodies through metagenomics, which analyzes 
the genome of all the microorganisms in a population as a whole and how they can react to different 
stimuli. 
 
2.1. Microbiome and Metagenome: 
 
Ten years once the term metagenomics was coined, the approach continues to collect momentum. 
Metagenomics is the study of genetic material of environmental samples of cohabit.  This scientific 
discipline makes it possible to sample the genome sequences of a community of organisms living 
in a common environment (Hugenholtz & Tyson, 2008).  
There is a wide variety of microbial communities and their genes, the microbiome, throughout the 
human body, with fundamental functions in human health and disease. In 2008, the National 
Institutes of Health of the United States (NIH) promoted a study with a five-year forecast under 
the name of Human Microbiome Project (HMP), where the effects of microbes, as well as viruses, 
bacteria and microorganisms, and how they influence the state of human health have been 
addressed. Where it was concluded that the human body contains more microbes than human cells 
(Group et al., 2009). The objective of HMP is to explain the microbe communities found in 
numerous elements of the human body and to obtain correlations between changes within the 
microbiome and also the health of individuals. Therefore, the bacteria found in the intestinal 
microbiota are a key part of HMP research, the composition of our intestinal bacteria affects the 
maturation of the human immune system and is a relevant factor in the development of not only 
gastrointestinal but also cardiovascular diseases. Its links with cancer and diabetes are under active 
investigation (Requena & Velasco, 2019) 
The diversity of microbes within a given habitat of the body can be defined as the distribution of 
the number and abundance of different types of organisms, which has been linked to various human 
diseases. It is estimated that there are between 500 and 1,000 species of bacteria throughout the 
human body, and each bacterial strain has a genome containing thousands of genes, offering 
substantially more genetic diversity and flexibility than the human genome. However, different 
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people host completely different collections of microbes with densities that vary substantially, 
even among conserved taxa, and little is understood about what leads to variation and what 
regulates it (Graph 2). Importantly, research still does not know how microbial variation within a 
person over time or among different people influences well-being, the preservation of health, or 
the onset and progression of disease (Gilbert et al., 2018). 
 
Figure 2. The human microbiome (gut, skin, bladder, and vagina, among other organs) and the factors that influence it: the 
human microbiome follows specific trajectories of the body site, so that each organism develops a specific biogeography. 
Excessive cleaning can temporarily alter the skin microbiome; changes in diet can profoundly affect the structure of the intestinal 
microbial community. The effect of antibiotics on all microbiomes is expected to be large relative to that of other factors, and 
preliminary studies have been conducted to determine their impact. It is also believed that lifestyle has a strong influence on the 
composition of the microbiome, for example exercise seems to influence the structure of the microbiome through the reduction of 
inflammation, resulting in subtle changes in the composition of the microbial community. Image created with Biorender.com 
In recent years, a great deal of evidence has been generated, reinforcing the importance of the 
human microbiome in health and disease through various mechanisms. The host microbiome also 
supplies a physical threshold that protects the host from extraneous micro-organisms, through 
competitive suppression and the development of antimicrobial agents (The Human Microbiota in 
Health and Disease | Elsevier Enhanced Reader). 
Early microbial exposure plays a critical role in the development of the immune, endocrine, 
metabolic and nervous systems (Requena & Velasco, 2019). In addition to the importance of 
adequate training of the immune system in the early stages of life, recent studies of microbiota 
alterations (dysbiosis) and their association with certain pathological conditions point to the 
decline in microbial diversity as one of the aspects contributing to the development of diseases, 
the reduction in species diversity of the human microbiome has been associated with an increase 
in pathologies (Sommer et al., 2017). Many autoimmune, allergic, endocrine-metabolic and 
gastrointestinal diseases are associated with microbial imbalance, making it a current issue in 
medicine and biology. 
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There is evidence that most diseases are not determined by genes; a clear example is cancer. The 
American Cancer Society in the United States has analyzed several genes associated with cancer 
in the last 50 years and there was only a 5% correlation between these diseases, globally, and 
certain genes. Therefore, the remaining 95% of cancer patients do not have a strictly genetic cause, 
but rather produced by the way human beings live and interact with the environment or the 
microbiome, with a host-microbiome lifespan interaction (Ariza-Andraca & García-Ronquillo, 
2016) . 
The most prominent examples are Helicobacter pylori, which is involved in the development of 
gastric cancer, and the high-risk types of human papillomavirus in cervical cancer. The interaction 
of microorganisms and their hosts is extremely complex, and a multitude of molecular mechanisms 
can be predicted by which they influence oncogenesis, tumor progression and response to cancer 
treatment (Garrett, 2015). 
 
2.1.1. The Urinary Microbiome: 
 
In 2008, when the results of the Human Microbiome Project were published, the microbiome of 
the urinary tract was not considered due to concerns about sampling techniques, microbiological 
methods and the concept of the urinary tract as a sterile niche. Thanks to new advances in advanced 
molecular techniques for the analysis of urine, the dogma that urine is sterile has been overturned 
and dysbiosis of the urinary microbiota has been linked to urological disorders. In view of this 
fact, the first results began to provide new insights into functional urological disorders (Aragón et 
al., 2018). Advances in 16S rRNA sequencing technology made it possible to discover the presence 
of a rich and diverse urinary microbiota in every individual, up to 80% of bacteria can be isolated 
using modified culture techniques. These novel technical approaches were used to investigate the 
composition of the urinary microbiota in patients diagnosed with functional disorders such as 
interstitial cystitis, urgency urinary incontinence, pelvic pain syndrome and bladder cancer. 
Bladder cancer is considered the ninth most common malignant disease, with over 160,000 deaths 
recorded worldwide each year. The risk of developing this tumor grows with age (Figure 3), and 
it is detected three times higher in men than in women (Sanli et al., 2017). In addition to 
environmental and genetic risk factors, researchers are increasingly aware that microbes in the 
human body play an important role in the maintenance of health and the development of disease 
(Bladder Cancer Risk Factors, American Cancer Society, 2019). 
Over the past five years, evidence has been collected that the urinary tract is home to a variety of 
commensal microorganisms, and the urinary microbiome reported for healthy individuals varies 
considerably due to the use of different analytical and sample collection methods. In general, it 
can be stated that there are differences related to sex and age, as well as significant inter-individual 
variability in the composition of the urinary microbiome (Aragón et al., 2018). 
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Figure 3. Bladder Cancer Risk Factors: According to the American Cancer Society, a risk factor is anything that affects your 
chance of getting a disease like cancer. Different cancers have different risk factors, in the case of bladder cancer there are risk 
factors that we can control such as lifestyle, not smoking, drinking water…, other factors such as race or genetics and family 
history, cannot be changed.  Having more risk factors will make a person more likely to present a bladder cancer. The overall 5-
year survival rate for people with bladder cancer is 77%. Image created with Biorender.com 
The urinary microbiome in bladder cancer has barely been investigated, the Xu et al. in 2015, pilot 
study reporting enrichment of Streptococcus sp. in some of the cancer patients. In 2018, in a study 
conducted by Bučević Popović et al., they analyzed urine samples from a total of 23 subjects: 12 
individuals with bladder cancer and 11 healthy controls, using 16S sequencing, showing no 
significant differences with respect to microbial diversity or overall microbiome composition. The 
authors did note, however, that Fusobacterium, a genus associated with colorectal cancer, was 
enriched in the urothelial cell carcinoma group. In the same year, Wu et al., conducted a study to 
characterize the urinary microbial community associated with bladder cancer; they collected urine 
samples from 31 male patients with bladder cancer and from 18 non-neoplastic controls using 16S 
sequencing. They identified an increased abundance of bacteria such as Herbaspirillum, 
Porphyrobacter and Bacteroides in cancer subjects with a high level of relapse and gradation, 
indicating that these types of OTUs are biomarkers for high-risk bladder cancer. 
In 2019 another study was carried out by Bi et al., where the same methodology was used; the 
urine samples of 29 patients with bladder cancer and 26 controls were compared. They discovered 
that the urine samples contained a microbiota preserved from Firmicutes, Actinobacteria, 
Proteobacteria and Bacteroidetes, constituting 94.4% of the bacteria in every situation; but only 
people with bladder cancer had a greater presence of Actinomyces europaeus, which may indicate 
that this strain is representative of bladder cancer (Bi et al., 2019). 
During this last year, the American Society of Clinical Oncology, conducted a study to characterize 
the urinary microbiota associated with muscle and muscle invasive bladder cancer; they collected 
urine samples from 27 patients with bladder cancer prior to transurethral resection or cystectomy 
and from 12 non-neoplastic control subjects based on age. The species most predominant in the 
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groups were Proteobacteria, Bacteroidetes, Firmicutes and Actinobacteria, but Bacteroidetes 
being a little more abundant in patients with bladder cancer. Interestingly, they found that non-
muscle invasive bladder cancer displayed a reduction in the abundance of Sphingobacteriaceae, 
Bifidobacteriaceae and Enterobacteriaceae. The study concluded that the urinary microbiota of 
patients with bladder cancer shows a totally different pattern compared to the lipid control, so the 
microenvironment of the tumor may influence the dysbiosis (Oresta et al.,2020).   
All these studies come to the same conclusion: the urinary microbiota may be a potential biomarker 
and therapeutic target for bladder cancer. But in order to identify which bacterial taxa are 
associated with this pathology it is necessary to carry out the correct statistical analyses; 
microbiome research and data analysis is one of the fastest growing sectors in biomedical and 
public health research, with an enhancement in the number of microbiome-funded studies and 
publications about statistical methodology on microbiome data. Because microbiome data is so 
complex, there is a critical need to develop all types of statistical methodologies for microbiome 
research, ranging from application to methodology to statistical theory (Xia et al., 2018). 
 
3. Microbiome Data: 
 
Microbiome data is generated, frequently, through 16S rRNA gene sequencing and shotgun 
metagenomics sequencing. Once the raw sequences have been pre-processed, there are two ways 
to generate microbiome data for further analysis (J. Chen et al., 2013). These 16S sequences are  
grouped into Operational Taxonomic Units (OTUs), according to their similarity (Caporaso et al., 
2010).  
Depending on the fields of research and the bioinformatics tools used to obtain this type of data, 
the structure of the microbiome and/or genome data is usually similar to contingency table per 
sample. This type of table usually has the samples as columns and the traits as rows. In general, 
the features refer to any of the characteristics of the OTUs and the "samples" are also items, i.e. 
the rows of the data array can be items, while the columns are variable. In the literature on 
microbiomes, researchers often use OTUs, taxa, genera and species to refer to characteristics. 
Thus, the primary data structure in the study of microbiomes is a table of taxa. Therefore, when 
working with microbiome data, these structures are referred to as taxa per sample or sample per 
table (Xia et al., 2018). 
Microbiome data have several features. Microbe count data (OTU counts) are limited, high 
dimension, poor and contain an excess of zero counts. In the OTU matrix, there are complicated 
correlation structures between various taxa, displaying a clear over-dispersion with great 
heterogeneities inside the group. Specifically, the OTU table records counts of different bacteria 
in samples extracted from the 16S rRNA sequencing. Each row of the table corresponds to a genus 
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while each column records a read count corresponding to a sample. The levels of phylum, class, 
family, order and species have the same data structures (Xia et al., 2018). 
Microbe sequence data sets are large, with tens of thousands of different categories. They are 
underdetermined, presenting a much larger number of OTUs than the number of samples 
(Tsilimigras & Fodor, 2016). The high dimensionality could result in the “large p, small n” 
problem (Yin & Hilafu, 2015) and poses statistical challenges to analyse microbiome data. High 
dimensionality is not the only problem with these data, taxon count data, whether taxonomy 
readings or OTUs counts, are often widely dispersed. This suggests that the variance of the counts 
is higher than that predicted by a multinomial regression (e.g. with the Poisson distribution). The 
over-dispersion in the data is due to the size of the library of DNA or RNA sequencing are widely 
different, and to the OTUs count ratios, because they differ much more than was expected under 
the multinomial regression proposed, like the Poisson model. (McMurdie & Holmes, 2014). 
In microbial data, dispersion is perceived as the absence of many taxa in the samples and zeros are 
generated in most experiments. The abundance of microbiome taxa, especially the abundance of 
taxa at lower taxonomic levels or OTU counts, are often high and highly skewed (Xia & Sun, 
2017). 
3.1. Zero inflation challenge: 
 
Microbiome count data are represented using OTUs from the 16S rRNA studies. For each 
specimen taken from a certain ecosystem, the number of occurrences of each OTU is measured 
and the resulting table of OTUs is summarized to obtain the relative abundance for the bacterial 
taxa in a specimen. An important feature of these data is that not all taxa can be present in each 
sample, i.e. some of the OTUs can take zero values. There is an urgent demand of statistical 
methods to analyse these complex microbial count data. This is an active area of research and a 
variety of statistical and computational methods have been proposed in the literature to answer a 
variety of questions. 
The excess of zeros in microbiome count data demonstrates a challenge in analyzing this type of 
data, especially when comparing two or more groups. A common strategy for managing these 
excess zeros is to use various probability models to model the excess zeros (Paulson et al., 2013; 
E. Z. Chen & Li, 2016). The problem with working with this type of model is that, in many cases, 
an implicit assumption is made that all zeros can be explained under a common probability model. 
In the count data modeling, three kinds of zeros are often referred based on the sources of zeros 
(Kaul et al., 2017): 
 Outlier Zeros: this kind of zeros are declared as outliers by the methodology employed; a 
taxon is recorded as outlier zero due to extraneous reasons, but not because it is below the 
detection limits due to the depth of the sample (Kaul et al., 2017). This definition has been 
found in only one article, Kaul et al. are the only ones that consider this type of zeros. 
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 Structural Zeros: in many occasions, due to the nature of the experimental groups, certain 
taxa are considered not to be present in the samples obtained from some groups, although 
they may be present in others (Kaul et al., 2017). A structural zero (Martín-Fernández et 
al., 2014), an essential zero (Aitchison & Kay, 2003; Martín-Fernández et al., 2014), 
genuine zeros, or the absolute zero (Martín-Fernández et al., 2014) refers to a given 
observation, when it is not correctly defined or simply cannot exist due to some 
deterministic reasons (van den Boogaart & Tolosana-Delgado, 2008). According to 
Aitchison and Kay in 2003, this type of zero means that "a component which is truly zero, 
not something recorded as zero simply because the experimental design or the measuring 
tool has not been able to detect a trace of the part".  
In summary, the zeros that truly represent the absence of taxa from a given sample belong 
to the structural zeros (Tsilimigras & Fodor, 2016). 
 
 Sampling or Counting Zeros: count data are categorical data, in which the count represents 
the number of items falling into each of several categories (Martín-Fernández et al., 2014). 
If an observed zero in the data cannot be qualified as an outlier or structural zero, then this 
zero is declared to be a sampling zero, perhaps caused by the depth of the sampling (Kaul 
et al., 2017). According to Martín-Fernández et al., this type of zero is due to a sampling 
problem, since the components may not be observed due to the limited sample size or be 
undetectable due to the limit of the techniques, i.e., the zeros are due to insufficiently large 
samples (Martín-Fernández et al. 2014). Unobserved positive values may be observed with 
a larger number of tests or with a different sampling design. Kaul and others claim that this 
type of zero is due to sampling depth, potentially due to the fact that the taxon is relatively 
rare compared to other taxa and due to technological reasons was not observed. 
Microbiome data have a large amount of zeros, either structural or sampling (e.g. biological and 
technical variability). Each individual has a unique composition of OTUs, because the taxa are 
dependent on the individual. The count of OTUs is, generally, characterized by an inflation of 
zeros (while one subject may have more than one hundred counts in a given OTU, many other 
subjects may have 0). (L. Xu et al., 2015). 
Structural zeros of the taxa are perceived in a certain sample because they are biologically or 
physically absent in the sample or in the subject. Sampling zeros are due to the true discovery of 
low-abundance taxa that are only found in a few samples (Tsilimigras & Fodor, 2016). 
 
3.2. Challenges of Modelling Microbiome Data: 
 
Taxa or OTUs are distributed throughout the samples (subjects), in the form of integer numbers or 
counts, and are not usually distributed according to a normal distribution. Ordinary regression 
Study of the distribution and behaviour of the “0” values in large omic data arrays                                     Helena Fidalgo Gómez  
  
11 
 
models, of which t-tests, ANOVA and ANCOVA are special cases, assume that the result is 
normally distributed and may produce a biased estimate of a treatment effect (and other factors) if 
that assumption is not met. This would imply, in practical terms, that the size of the treatment 
effect and its statistical significance are either overestimated or underestimated, which is not 
appropriate (Hu et al., 2011). 
In the last decades, we have seen the increasing development and availability of statistical methods 
for parametric models whose data are not distributed according to a normal distribution, and which 
respond to the challenges currently facing biostatistics with microbial count data. These challenges 
are (Xia et al., 2018): 
i. Reduce dimensions and solve large p and small n problem. 
ii. Identify and manage "rare" taxa. 
iii. Model the microbiome data with over-dispersion and inflation of zeros. 
 
Over-dispersion is the main issue in the analysis of 16S rRNA sequence data (Tsilimigras & Fodor, 
2016), so handling over-dispersion with excess zeros is the key issue in the analysis of microbiome 
data. 
 
Over-dispersion with excess zeros poses critical challenges in parametric models in order to 
calculate accurate estimates of variance for meaningful inference and even such estimates are 
essentially impossible on samples that consist mostly of zeros (Tsilimigras & Fodor, 2016). When 
taxa or OTUs are over-dispersed with excess zeros, the abundance distribution and the probability 
of occurrence distribution of the taxa are both skewed, giving rise to zero inflation  (J. Chen et al., 
2013). 
 
Classical linear models that apply to untransformed counts or log transformed counts are 
inappropriate for zero inflated count data, as they would violate the normality and homogeneity of 
variance assumptions, and are not relevant for relative abundance either (L. Xu et al., 2015). An 
example would be relative abundances, which are limited to between zero and one and where the 
variance is usually dependent on the mean. In addition, no data transformation can satisfy the 
assumptions if there is an excess of zeros; logistic regression, which considers all zero counts as 
"non-events", is generally used for modelling data with excess zeros; the problem with applying 
this method is the loss of information and power to detect the effect of a covariate (L. Xu et al., 
2015). When faced with generalized linear models, such as Poisson's or the Binomial Negative 
model, which can be applied to count data (since they work with discrete and non-negative data), 
they cannot deal with the excess of zeros either, because a basic requirement of these models is 
that the proportion of zeros must necessarily be linked to the distribution of positive values (Xia 
et al., 2018). Thus, the abundance of OTUs with excess zeros cannot be modelled by any standard 
parametric model (Martin et al., 2005). 
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Over-dispersion with zero inflation also does not allow the application of non-parametric methods. 
If non-parametric methods that do not assume the assumption of normality are applied, such as the 
Wilcoxon rank sum test, covariates could not be incorporated, and a large loss of power would be 
assumed due to the large number of ties caused by many zeros. In addition, these methods are 
based on ranges or medians, so they tend to be more "robust" to outliers and prevent variance 
estimates that may be biased by small samples (Martín-Fernández et al., 2014). On occasions when 
many OTUs have an excess of zeros and few positive count values, they will not have sufficient 
statistical power to be able to make an inference about these types of taxa, using non-parametric 
methods. (Xia et al., 2018) . 
 
Overall, both traditional parametric models and non-parametric methods are not suitable for 
analysing data on microbiomes with over-dispersion and excess zeros. Therefore, the analysis of 
this type of data is a real challenge and if excess zeros are not taken into account, biased parameter 
estimates, and misleading inferences can occur (Xia & Sun, 2017; Xia et al., 2018; L. Xu et al., 
2015). 
4. Statistical Methods for Microbiome Data: 
 
For each specimen taken from an ecosystem, the number of occurrences of each OTU is measured 
and the resulting table of OTU is summarized to obtain the relative abundance of bacterial taxa in 
a specimen. These OTU counts can be summarized at any level of the bacterial phylogeny, e.g. 
species, genus, family, order, etc. (Kaul et al., 2017).  If, for example, a group comparison is 
desired, there are classical methods that can be used: depending on whether the data are normally 
distributed or not, on the number of experimental groups or on the experimental conditions, a t-
Student, an analysis of variance (ANOVA) or a corresponding non-parametric test can be applied. 
For example, t-test was used to compare alpha diversity (La Rosa et al., 2015) between two sets 
of relative abundance data. The non-parametric analogous Wilcoxon rank sum test was conducted 
to compare alpha diversity, like, Shannon diversity (La Rosa et al. 2015). Wilcoxon rank sum test 
was also used to identify the differences in OTUs and the relative abundances of different phyla 
and genera (Wang et al., 2012). When comparing more than two groups, the ANOVA test or its 
non-parametric equivalent, the Kruskal-Wallis test, is used. The Chi-Square test is generally used 
to compare categorical microbiome data, for example, testing if a single a priori specified taxon is 
present at different rates across groups (La Rosa et al. 2015). 
In this type of situation, the classic methods do work, but when the objective is to model this type 
of data, it is necessary to propose different methods. The abundance of the taxa in human samples 
is characterised by a greater number of zeros at lower taxonomic levels. In order to model the 
excess of zeros, over-dispersion and heterogeneity presented by microbiome count data, it is 
necessary to apply models that move away from classical linear models, such as the Zero-Inflated 
model or the Zero-Hurdle model. (L. Xu et al., 2015).  
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Before defining these models, it is necessary to clarify the excess of zeros and the clear over-
dispersion of microbial data. Figure 4 shows an example of a real case of Finegoldia magna, that 
is part of the database that will be used in this project and will be shown later how to solve it: 
 
 
 
 
 
 
 
 
 
 
Figure 4. Frequency of Count of an OTU with excess of zeros. The Y-axis shows the 433 subjects that make up the database and 
the X-axis shows the counts of each of these subjects. The graph above shows the frequency of "counts" for a specific bacterium 
(taken at random), as can be seen, out of 433 subjects in total: 430 subjects have 0 counts in this OTU, two subjects have less 
than or equal to 3 counts and one subject has 89 counts. Therefore, the excess of zeros is very large, and the variance far exceeds 
the expected value (𝑉𝑎𝑟(𝑂𝑇𝑈𝑖) = 18.28 >  𝐸(𝑂𝑇𝑈𝑖)  =  0.22), confirming that present overdispersion. Graph created in 
RStudio with the "ggplot2" package. 
Count data is discrete data, non-negative integer (ℤ ≥ 0), and are modelled according to a ℙoisson 
or a ℕ egative 𝔹 inomial distribution. If a 𝔾 aussian distribution were used, a least-squares 
regression would be carried out, where the count data would violate the distribution assumptions 
on which the normal model is based and produce statistically biased results. The central problem 
is that the standard model assumes that negative values are possible and that the variance of the 
variable being modelled is constant across its range of values. These assumptions are not possible 
for count data (Hilbe, 2017).   
 ℙoisson Distribution is the discrete probability distribution of the number of events 
occurring in a given time period, so it can take any integer value greater than or equal to 
zero. A random variable 𝑋  follows a Poisson distribution of parameter 𝜆 > 0  and is 
denoted by 𝑋 ~ 𝑃(𝜆) , if for 𝑘 ∈ {0, 1, 2, 3, . . . } , the probability function is given by 
(Inouye et al., 2017): 
 
𝑃(𝑋 =  𝑘) =
𝜆𝑘
𝑘!
𝑒−𝜆                                                                                     (1) 
Where 𝜆  indicates the average number of events in the given time period. A central 
criterion of the Poisson distribution is that mean and variance of the counts being modelled 
are identical (Inouye et al., 2017): 
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𝔼(𝑋) = 𝜆;                   𝕍𝑎𝑟(𝑋) = 𝜆                                                               (2) 
 
 ℕegative 𝔹inomial Distribution is a discrete probability distribution of the number of 
successes in a sequence of independent and identically distributed Bernoulli trials before a 
specified number of failures (denoted 𝑟 ) occurs. So, a random variable X follows a 
Negative Binomial distribution of parameters 𝑟 ∈ ℕ and 𝑝 ∈  (0,1), and is denoted by 
𝑋 ~ 𝑁𝐵(𝑟, 𝑝), the probability function is given by (Fisher, 1941): 
 
𝑃(𝑋 = 𝑘) =  (
𝑟 + 𝑘 −  1
𝑟 −  1
) 𝑝𝑟(1 −  𝑝 )𝑘                                                 (3) 
 
Where the mean and variance are defined by (Fisher, 1941): 
 
𝔼(𝑋) =
𝑟(1 −  𝑝)
𝑝
;         𝕍𝑎𝑟(𝑋) =
𝑟(1 −  𝑝)
𝑝2
                                        (4) 
As discussed in previous chapters, microbiome data are represented by an excess of zeros, which 
can be of three types, Outliers, Structural and Sampling, and depending on the origin of these 
zeros, they will fit one type of distribution better than another. If the data fit better to a ℙoisson 
distribution, it is because the zeros it contains are outliers and structural, whereas, if they fit better 
to a ℕegative 𝔹inomial distribution it is because it contains outliers, structural and sampling zeros. 
Therefore, sampling zeros are the ones that cause the over-dispersion that must be modelled with 
ℕegative 𝔹inomial distribution (Tang et al., 2018, Kaul et al., 2017,  L. Xu et al., 2015, HE et al., 
2014). 
4.1. Models for count data with excess of zeros: 
 
The main objective is to determine if the abundance of a certain OTU is related to some 
environmental or genetic factor; but currently there is no standard method to evaluate such 
relationships (L. Xu et al., 2015) .  
As already mentioned in the Section 2.2, classical linear models, using non-transformed or 
logarithmic transformed counts are inappropriate for zero inflated counts due to the violation of 
normality and constant variance assumptions. In addition, no data transformation can meet the 
assumptions if there are too many zeros (L. Xu et al., 2015, Kaul et al., 2017, Xia & Sun, 2017). 
If a logistic regression is applied, it would treat all zero counts as non-events, resulting in a loss of 
valuable information and power to detect the effect of a covariate. Generalized linear models such 
as ℙoisson or ℕegative 𝔹inomial can be applied on sequence counts and the logarithm of total 
sequence reads can be set as an offset; however, they could not model the excess of zero either, 
since a basic requirement of these models is that the proportion of zeros must be linked to the 
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distribution of positive integer values (Xia et al., 2018, L. Xu et al., 2015). One way to handle 
excess zeros is to apply either a Zero-Inflated (ZI) model or a two-part model, also called the Zero-
Hurdle model. With the Zero-Inflated models a better result will be obtained if outliers and 
structural zeros are being modelled, on the other hand, the hurdle models do not distinguish 
between the different types of zeros and model them perfectly, independently of their origin (L. 
Xu et al., 2015): 
 
i. Zero Inflated Models: 
This type of model is based on a distribution that allows for zero-valued observations, i.e. it is 
based on a zero inflation probability distribution (this is the name given to the regression model). 
The zero inflated models include Zero Inflated Poisson (ZIP) and Zero Inflated Negative Binomial 
(ZINB); they assume that for each observation, there are two possible data generation processes, 
and then a Bernoulli trial determines which process is used (L. Xu et al., 2015).  
ZIP assumes that each observation comes from one of two potential distributions, one consisting 
of a constant zero while the other following a Poisson distribution. In this model, a logit model is 
typically used to analyse the probability of the outlier zero or structural zero, whereas the count 
data is analysed by the Poisson regression (Hu et al., 2011) .  
Specifically,  if the outcome variable for the 𝑗𝑡ℎ individual, 𝑌𝑗 , follows a ZIP distribution, then its 
probability is given by (Xia et al., 2018) :  
𝑃(𝑌𝑗 = 0|𝑋𝑗) = 𝑝𝑗 + (1 − 𝑝𝑗)  ∗  𝑒
(−𝜇𝑗);                                                         (5) 
𝑃(𝑌𝑗 = 𝑦𝑗| 𝑋𝑗) = (1 − 𝑝𝑗)  ∗
𝑒𝑥𝑝(−𝜇𝑗)(𝜇𝑗)
𝑦𝑗
𝑦𝑗!
;  𝑦𝑗 = 1, 2, 3, …                  (6) 
Where 𝑝𝑗 is the probability of structural or outlier zero, (1 − 𝑝𝑗) is the probability of sampling 
zero, 𝜇𝑗  and 𝑋𝑗  are the expected Poisson count and covariate vector respectively, for the 𝑗
𝑡ℎ 
individual. 
From the first situation, it obtains that the observed zeros arise from both the zero-component 
distribution and the Poisson distribution. i.e., the two sources of structural and outliers’ zeros, and 
sampling zeros. Therefore, the zero-component distribution provides the capability to model the 
“excess” zeros that are observed in addition to the zeros that are expected to be observed under the 
assumed Poisson distribution. By replacing the Poisson distribution for the count data in ZIP with 
the Negative Binomial distribution, it obtains the Zero-Inflated Negative Binomial distribution, or 
ZINB (Xia et al., 2018). Thus, a ZINB has the general form: 
𝑃(𝑌𝑗 = 0|𝑋𝑗) = 𝑝𝑗 + (1 − 𝑝𝑗)𝑔(𝜇𝑗);                                                                   (7) 
𝑃(𝑌𝑗 = 𝑦𝑗| 𝑋𝑗) = (1 − 𝑝𝑗)𝑓(𝜇𝑗) ; 𝑦𝑗 = 1, 2, 3, …                                               (8) 
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Where 𝑔(𝜇𝑗) = 𝑃(𝑌𝑗 = 0| 𝑋𝑗) = (
𝛼−1
𝜇𝑗+𝛼
−1)
1
𝛼⁄
in the count data model, and 𝑓(𝜇𝑗) is the density of 
the Negative Binomial distribution; α is the dispersion parameter: 
𝑓(𝜇𝑗) =
𝛤(𝑦𝑗 + 𝛼
−1)
𝑦𝑗! 𝛤(𝛼−1)
∗ (
1
1 + 𝛼𝜇𝑗
)
1
𝛼⁄
∗ (
𝛼𝜇𝑗
1 + 𝛼𝜇𝑗
)
𝑦𝑗
;   𝛼 > 0, 𝑦𝑗 ≥ 0    (9) 
The binary process can be modeled using either logit, probit or other models for binary outcomes. 
For ZINB, 𝑉𝑎𝑟(𝑌𝑗| 𝑋𝑗) > 𝐸(𝑌𝑗| 𝑋𝑗),  demonstrating that ZINB has the capability to model 
overdispersion. If we compare the ZIP and ZINB model, the main advantage of the ZINB is that 
the Binomial Negative distribution models the overdispersion and solves all sources of 
heterogeneity presented in the data. While the ZIP model, being based on a Poisson distribution, 
focuses on the heterogeneity created by the atypical and structural zeros. As Poisson is nested 
within Negative Binomial, ZIP is nested within ZINB; ZINB can be viewed as an extension of ZIP 
in analogous to Negative Binomial distribution being an extension of Poisson distribution (Hu et 
al., 2011). 
ii. Two-part Models or Zero-Hurdle Models:  
The Hurdle model was developed separately by Mullahy in 1986: “The idea underlying the hurdle 
formulations is that a binomial probability model governs the binary outcome whether a count 
variate has a zero or a positive realization (i.e., a transition stage). If the realization is positive the 
‘hurdle’ is crossed, and the conditional distribution of the positives is governed by a truncated-at-
zero count data model”. 
In short, one distribution addresses the zeros while another distribution addresses the positive 
nonzero counts, such as a truncated Poisson or truncated Negative Binomial distribution (Min & 
Agresti, 2005). It is a “finite mixture generated by combining the zeros generated by one density 
with the zeros and positives generated by a second zero-truncated density separately…” (Mullahy, 
1986). A very important characteristic of the transition model is asymmetry, which means that the 
probability of crossing the obstacle increases as the covariates increase, and decreases as the 
covariates decrease. 
Mullahy demonstrated that hurdle models naturally admit overdispersion and underdispersion of 
data, and because of this, give better results than Zero-Inflated models; given any two probability 
distribution functions for non-negative integers 𝑓1 and 𝑓2, presenting the hurdle part and the parent 
process, the hurdle-at-zero model has the probability distribution (Mullahy, 1986): 
 
𝑃(𝑌 = 0) =  𝑓1(0)                                                                                        (10) 
𝑃(𝑌 = 𝑦) = 𝑓2(𝑦) ∗
1 − 𝑓1(0)
1 − 𝑓2(0)
= 𝛷𝑓2(𝑦);   𝑦 = 1,2, …                        (11) 
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Because 𝑓1(0) is essentially used to establish the event of crossing the hurdle (i.e., if the count is 
zero), is defined 𝑃(𝑌 = 0) = 𝑝𝑗 and 𝑃(𝑌 ≥ 1) = 1 − 𝑝𝑗 , and used a logistic regression to model 
𝑝𝑗 . The numerator of 𝛷 can be interpreted as the probability of crossing the hurdle (in microbiome 
data would be interpreted as: in case of bacteria species (OTU), the probability to present at least 
one count) and the denominator is a normalization for 𝑓2. It follows immediately that the hurdle 
model collapses to the parent model if 𝑓1 = 𝑓2, 𝛷 = 1 (Mullahy, 1986).  
Since the zero hurdle model has two stages, a link function is applied for each stage: 
 For the logistic regression: 
         ln (
𝑝𝑗
1 − 𝑝𝑗
) = 𝑋𝑗𝛼                                                                                         (12) 
 For the truncated model:  
 
ln(𝜇𝑗) = 𝑋𝑗𝛽                                                                                               (13) 
Where 𝛼 and  𝛽 are the sets of regression coefficients for the stages 1 and 2, respectively. One 
thing that needs to be stressed is that different prediction variables X could be used at each stage 
of the model, as the prediction variables that would be applied at the first stage may not be the 
same as those that would be applied at the second stage (this would be applied in multiple 
regression models). 
Zero-Hurdle Poisson Model (ZHP) is a two-component model: a hurdle component models the 
zero versus the non-zero counts, and a truncated Poisson count component is employed for the 
non-zero counts (Xia et al., 2018):  
𝑃(𝑌𝑗| 𝑋𝑗) = 𝑝𝑗                                                                                                         (14) 
𝑃(𝑌𝑗 = 𝑦𝑗| 𝑋𝑗) = (1 − 𝑝𝑗) ∗
𝑒𝑥𝑝(−𝜇𝑗)(𝜇𝑗)
𝑦𝑗
𝑦𝑗! (1 − 𝑒𝑥𝑝(𝜇𝑗))
;  𝑦𝑗 > 0                          (15) 
Specifically, zero-hurdle models do not make the distinction between outliers, structural and 
sampling zeros and handle them identically: unlike 𝑝𝑗 in the zero-inflated model, the 𝑝𝑗 in zero-
hurdle model does not model the excess zeros, but all zeros (Xia et al., 2018).  
The Zero Hurdle Negative Binomial model (ZHNB) is obtained by replacing the zero-truncated 
Poisson with a truncated Negative Binomial model to analyze the truncated-at-zero count: 
𝑃(𝑌𝑗| 𝑋𝑗) = 𝑝𝑗                                                                                                           (16) 
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𝑃(𝑌𝑗 = 𝑦𝑗| 𝑋𝑗) = (1 − 𝑝𝑗) ∗
𝛤(𝑦𝑗 + 𝛼
−1)
(1 − (
𝛼−1
𝛼−1+𝜇𝑗
)
1
𝛼⁄
)𝛤(𝑦𝑗 + 1)𝛤(𝛼−1)
∗ (
𝛼−1
𝛼−1 + 𝜇𝑗
)
1
𝛼⁄
∗ (
𝜇𝑗
𝛼−1 + 𝜇𝑗
)
𝑦𝑗
;    𝑓𝑜𝑟 𝑦𝑗 > 0                                                       (17) 
Where 𝛼(≥ 0) is a dispersion parameter that is assumed not to depend on the covariates. It can be 
seen in above equation, that the positive count is governed by a truncated-at-zero negative binomial 
as the probability function for the positive count is divided by 1 minus the probability function of 
a negative binomial evaluated at zero (Xia et al., 2018). 
So far, it has been described and differentiated between Zero Inflated models and Zero Hurdle 
models from modelling and concepts. In general ZIP vs. ZHP, ZINB vs. ZHNB, respectively give 
similar model fit and predicted values, but different estimated parameters. These two models differ 
from their interpretation of model parameters, conceptualization of zeros and their capacity to deal 
with excess zeros. Zero-inflated models fit better if the zeros presented by the variable are outliers 
or structural; if it is analysed in the scope of these models, the following link functions can be 
specified for the count and the binomial data, respectively (𝑥𝑗 is used to indicate the covariate): 
𝜇𝑗 = 𝑒𝑥𝑝(𝛼 + 𝛽 ∗  𝑥𝑗)                                                                                    (18) 
 𝑝𝑗 =
𝑒𝑥𝑝(𝜐 +  𝛾𝑥𝑗)
1 + 𝑒𝑥𝑝(𝜐 +  𝛾𝑥𝑗)
                                                                                (19) 
The mean 𝜇𝑗 for the Poisson count data is modeled in terms of the covariate 𝑥𝑗 and the probability  
𝑝𝑗 for the Binomial distribution with a same covariate 𝑥𝑗. The set of covariates for the both models, 
Poisson count data and Binomial data, can be different, that's why different parameters are used. 
Hurdle models do not distinguish between outliers, structural, or sampling zeros, and assume that 
all zeros come from a single population, and actually, the formulation of the zero-hurdle models 
does not tell us the source of zeros. Again, it should be emphasized that these models have two 
components: a hurdle component for zeros versus non-zeros and a truncated count component for 
positive counts. Therefore, they model zeros separately from positive counts: these treat the data 
as a level of presence and absence and analyse the presence data with a count model. In microbial 
data this is an advantage compared to zero-inflated models, as these models do not differentiate 
between zeros and fit better, since it is difficult to differentiate zeros into outliers, structural and 
sampling zeros from conceptual and data generation perspectives. 
 
In ZIP and ZINB models, binomial regression models the probability of a structural zero and/or 
outlier versus other types of count data, while in ZHP and ZHNB, it models the probability of 
presence versus absence of a bacterium. Hence, the estimated regression parameters obtained by 
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ZHP and ZHNB have opposite signs from those obtained by ZIP and ZINB due to the different 
definition of 𝑝𝑗. 
Finally, to carry out these models, applying them to microbiome data, it is necessary to declare an 
offset. The offset will be adjusted as a covariate in the model later to ensure microbiome response 
is relative abundance instead of count data. This is a very important step to be able to fit models 
in the study of microbiome data (Xia et al., 2018). The offset argument can also be set only for the 
count model; so if it takes the link function for truncated model of the zero hurdle model and if the 
offset is added the equation would look like: 
ln(𝜇𝑗) =  𝑋𝑗𝛽 + ln(𝑂𝑓𝑓𝑠𝑒𝑡𝑗) = 𝑋𝑗𝛽 + 𝑜𝑓𝑓𝑠𝑒𝑡𝑗                                                          (20) 
 
4.2. Model Selection: 
As the statistician George Edward Pelham Box, said: "All models are wrong. Some models are 
useful", it is essential to establish whether the statistical model or models selected, to address a 
particular issue, are not wrong, since they would lead us to assume useless or incorrect conclusions 
on important aspects of the hypothesis in question. In most real-world data analysis situations, 
researchers consider several statistical models that might be appropriate for application. Thus, 
different criteria need to be addressed in order to choose the model that will give the best result 
and to which the data will best fit. 
Commonly the models: ZIP vs. ZHP and ZINB vs. ZHNB, offer a similar fit to the model and 
predicted values, but different estimated parameters. The main difference between these models is 
the interpretation of the parameters, their competence to work with the excess of zeros and in the 
concept of the zeros that they model. The main issue is to determine which distribution and which 
model is best suited to deal with this type of data, so each of these should be compared using 
likelihood ratio test, Akaike's information criterion (AIC), Bayesian information criterion (BIC) 
and Vuong test (Xia et al., 2018, Xia & Sun, 2017, L. Xu et al., 2015, Hu et al., 2011). Nested 
models are compared using the likelihood or score test, while non-nested models are evaluated 
using the AIC, BIC and/or Vuong test. Nested models include ZIP versus ZINB, and ZHP versus 
ZHNB; and non-nested models include ZIP versus ZHP and ZINB versus ZHNB (Xia et al., 2018). 
I. Akaike’s information criterion: AIC is one of the traditional model-comparison criteria; 
it can be used for comparing non-nested models (Bozdogan, 1987). The key idea of this 
criterion is to penalize an excess of adjusted parameters. AIC is used to choose between 
non-nested mixture models (Xia et al., 2018). It is defined as: 
 
𝐴𝐼𝐶(𝑘) = −2 𝑙𝑛ℒ[𝜃(𝑘)]  +  2𝑘                                                                          (21) 
Where ℒ[𝜃(𝑘)]  is the likelihood function, 𝜃(𝑘) is the maximum likelihood estimate of the 
parameter vector 𝜃 and k is the number of independent parameters estimated within the 
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model, while ln denotes the neperian logarithm (Bozdogan, 1987). The smaller the AIC 
value, the better the model fit. 
II. Bayesian information criterion: in the context of procedures based on likelihood, 
Schwarz in 1978, suggested that the AIC might not be asymptotically justifiable and 
presented an alternative information criterion based on a Bayesian approach, the BIC, with 
this criterion penalizing the number of parameters with 𝑙𝑛(𝑛), instead of two; expressed 
as: 
𝐵𝐼𝐶(𝑘) = −2𝑙𝑛ℒ[𝜃(𝑘)] + (𝑙𝑛 𝑛)𝑘                                                                   (22) 
 
Where ℒ[𝜃(𝑘)]  is the likelihood function, 𝜃(𝑘) is the maximum likelihood estimate of the 
parameter vector 𝜃 and k is the number of independent parameters estimated within the 
model, while 𝑛 is the sample size (Schwarz, 1978) . 
As in the previous criterion (AIC), the penalties are used to reduce the effects of overfitting 
and note that the penalty is more robust for BIC than AIC, regardless of sample size. 
Because this criterion (BIC) applies a more robust penalty, for the estimation of each 
additional covariate, it generally selects those models that are more simplified (that is, it 
chooses the model with the least number of covariates). Because the microbiome data have 
high heterogeneity (as explained in previous chapters), the criterion that will best select the 
model will be the BIC (Xia et al., 2018). 
 
III. Likelihood Ratio test: this test evaluates the goodness of fit of two nested statistical 
models based on the relationship of their probabilities, specifically one found by 
maximization across the parameter space and another found after some restriction is 
imposed (Kent, 1982). 
 
IV. Vuong test:  the objective of this test is to compare two non-nested models (𝑓1 and 𝑓2) that 
fit the same data through maximum likelihood; the null hypothesis assumed is that the both 
models fit the data equally well. This test does not require that the models be nested, nor 
does one of the models need to represent the correct specification (Kent, 1982). 
 
The specific metric of model fit is the Kullback-Leibler Divergence (KLD) from the true 
model that generated the data (𝑓𝑡), it is a measure of the distance between two probability 
distributions and is the basis for other measures of model comparison or selection, such as 
the AIC (Kent, 1982) . The null hypothesis that dominates this test is: 
 
𝐻0: 𝐷𝐾𝐿(𝑓𝑡||𝑓1) = 𝐷𝐾𝐿(𝑓𝑡||𝑓2)                                                                      (23) 
 
Where 𝑓𝑡 and 𝑓1 𝑜𝑟 𝑓2,  are counting models for non-negative integers. This test is mainly 
used in models that deal with excess zeros, such as zero-inflated and zero-hurdle models, 
since it is associated with the test of overdispersion and zero inflation (Xia et al., 2018). 
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The Vuong test is defined as the average of the logarithmic probability ratio conveniently 
normalized so that it can be compared with a standard normal: 
 
𝑉 =
√𝑛  ∗  ?̅?
𝑆𝑚
                                                                                                      (24) 
Where 𝑛 is the sample size, 𝑆𝑚 is the standard error of the test statistic, ?̅? = (
1
𝑛
)∑ 𝑚𝑖
𝑛
𝑖=1  
and 𝑆𝑚
2 = (
1
𝑛−1
)∑ (𝑚𝑖  −  ?̅?)
2𝑛
𝑖=1 , and 𝑚𝑖 = log [
𝑓1(𝑦𝑖)
𝑓2(𝑦𝑖)
] (Xia et al., 2018). 
If the Vuong test selects two models as valid, the Rootograms and Q-Q Plots of the models will be 
carried out in order to establish the model that best fits the data: 
V. Rootograms: The Rootograms are used to display count data regressions, these plots 
compare observed and expected values graphically by plotting histogram-like rectangles 
or bars for the observed frequencies and a curve for the fitted frequencies, all on a square 
root scale. The square roots rather than the untransformed observations are employed to 
approximately adjust for scale differences across the values or intervals. Otherwise, 
deviations would only be visible for large observed/expected frequencies. The most 
popular Rootograms are denominated “Hanging”, these align all deviations along the 
horizontal axis, the bars are drawn from √𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑 to √𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑 − √𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 so that 
they are “hanging” from the curve representing expected frequencies. The abscissa axis, 
positioned at 0, will indicate whether the model is over- or under-fitting. 
 
VI. Q-Q Plots: in the Quantile-Quantile (or Q-Q) graphs of random versus corresponding 
theoretical standard quantile residuals, it is checked whether the residuals fit correctly on 
the line and are between the limits of -2 and 2, thus confirming the hypothesis of normality 
of the residuals (Dunn and Smyth 1996). 
 
4.3. Models for count data without excess of zeros:  
 
So far, only models dealing with excess zeros have been analysed, but when working with 
microbiome data, cases with no or very few zeros can also be found, and therefore previous model 
are not appropriate. Two more methods for working with counts data without excess zeros will be 
shown below: 
Generalized Linear Models (GLM) extend the familiar linear models of regression and ANOVA 
to include counted data; the Poisson GLM is particularly useful for count data as these tend to be 
heterogeneous and are always non-negative, and the Negative Binomial GLM has the same 
advantages as the Poisson distribution with the difference that it allows to model data with 
overdispersion. A GLM consists of three steps: 1. the distribution of the response variable (where 
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the distribution of Poisson or the Binomial Negative would be specified), 2. the specification of 
the systematic component in terms of explanatory variables, 3. the link between the mean of the 
response variable and the systematic part (in this case, the link function will be the logit)  (Zuur 
et al., 2009) . To determine which model best fits the data, it is necessary to use the same criteria 
explained in the previous section. 
In 2014 Love, Huber and Anders proposed a binomial negative model for differential analysis of 
count data, which is in the DESeq2 package from RStudio and is based on the methodology 
developed by Robinson and Smyth in 2010. This package was reviewed as one of the most popular 
implementations of the variance stabilization technique currently used in RNA Seq-analysis and 
can be adapted for microbe count data (McMurdie & Holmes, 2014) . This approach allows a valid 
comparison between OTUs, while substantially improving both power and accuracy in detecting 
differential abundance (Xia et al., 2018). 
These models account for the biological variations in the count data of the high-yield sequencing 
by means of the mean-variance relationship (Xia et al., 2018): 
𝑉𝑎𝑟(𝑌𝑖𝑗) = 𝜇𝑖𝑗 ∗ (1 + 𝜇𝑖𝑗𝜙𝑖)                                                                       (25) 
Where it can be seen that the variance and mean are linked by a local linear regression. 
𝑌𝑖𝑗  represents the number of readings in sample j that was assigned to 𝑂𝑇𝑈𝑖,  then 
𝑌𝑖𝑗 ~ 𝑁𝐵(𝜇𝑖𝑗 , 𝜎𝑖𝑗
2) ;. 𝜙𝑖  is a single proportionality constant that is the same throughout the 
experiment and can be estimated from the data (McMurdie & Holmes, 2014). 
  
5. Objectives: 
 
The main objective of the present work is to analyse the distribution and behaviour of the "0" 
values in the large matrix of omics data. In order to achieve this general objective, a series of sub-
objectives must be raised that will allow us to reach the final goal: 
I. Determine when you are working with "excess" zeros. 
II. With what maximum percentage of zeros, the models converge. 
III. What types of zeros are contained in the bacteria that make up the database. 
IV. Select the model that best fits and model the count data with excess zeros and 
overdispersion. 
V. Analyse the behaviour of zeros for categorical covariates, of 2 or more levels. 
VI. Carry out the Vuong Test, in different scenarios, to check if you always select the same 
model as the best. 
VII. Determine if the abundance of a given OTU is associated with any environmental or 
genetic factors. 
All these sub-objectives will be carried out and analysed, throughout the Master Thesis. 
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6. Application to a real database: 
 
All the above models will be tested and applied to two real databases: Kraken Counts database 
(Table 1) and metadataBCLA_RNA (Table 2). Both databases come from The Cancer Genome 
Atlas project (TCGA). 
The Cancer Genome Atlas a landmark cancer genomics program, molecularly characterized over 
20,000 primary cancers and matched normal samples spanning 33 cancer types. During the 
following 12 years, the TCGA originated more than 2,5 petabytes epigenomic, genomic 
transcriptomic, and proteomic source data. All these data are available to any laboratory in the 
research community. The databases that have been taken from the TCGA to carry out this final 
master's thesis, are those related to Urothelial Bladder Carcinoma (BLCA), (Thorsson et al., 2018). 
The first database to be described is Kraken Counts database (Table 1), this database was 
developed thanks to the Kraken tool, this is a popular taxonomic classification tool for 
metagenomic and microbiome sequencing results.  
The database contains a total of 433 muscle-invasive bladder cancer patients included in the TCGA 
Consortium and 4,263 different bacteria. The bacterial count of a certain type, which each subject 
contains, is displayed. In addition, the taxa identification number of each bacterium and the sum 
of the counts that each one has in the 433 patients is shown. As it can be seen, there is a very large 
difference between some bacteria and others, while some present more than 5 million counts across 
the 433 patients, others present a very low total of 10 counts or even a single count across the 
subjects.  Kraken Count database contains both bacteria that were found in bladder tumours and 
bacteria that are part of our usual microbiome (of the urinary tract, intestinal tract, skin, ...). 
Table 1. Summary table of the Kraken Counts database. 
taxID … Specie Total
96344 0 16 0
…
 
0 Cupriavidus oxalaticus 9405657
1491 0 41092 2
…
 
0 Clostridium botulinum 2621385
2184519 1 19060 0
…
 
33 Hydrogenophaga sp. NH-16 1496395
1358 0 2 0
…
 
0 Lactococcus lactis 333344
1396 0 3012 27
…
 
1 Bacillus cereus 324567
1747 18 531 28
…
 
31 Cutibacterium acnes 128398
1286 4 0 33
…
 
374 Staphylococcus simulans 47105
339 0 53 1
…
 
0 Xanthomonas campestris 33067
573 81 81 50
…
 
53 Klebsiella pneumoniae 31519
1275 0 4 1
…
 
0 Kocuria rosea 22691
550 82 71 14
…
 
42 Enterobacter cloacae 21275
485 80 55 21
…
 
47 Neisseria gonorrhoeae 19264…
 
…
 
…
 
…
 
…
 
…
 
…
 
…
 1003110 0 0 0
…
 
0 Verrucosispora maris 0
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MetadataBCLA_RNA contains a total of 119 different variables, of the same 433 muscle-invasive 
bladder cancer patients included in the TCGA Consortium and sampled to form the Kraken Count 
database. This database is the result of merging 3 different databases: it contains 39 different gene 
expressions, 75 variables related to the immune system response and the rest are either tumour 
characteristics (such as stage, sample type, tissue or organ of origin, site of resection or biopsy, ...) 
or subject-related characteristics (such as gender, race, weight, BMI, number of cigarettes smoked 
per day, etc.) All these variables are related to bladder cancer. For example, within the 39 gene 
expression variable, 10 are called Toll-Like Receptors (TLRs) and they play key roles against 
cancer (Ohadian Moghadam & Nowroozi, 2019). Within the variables, classified as immune 
system response, several are related to the T Cell Receptor (TCR) and B Cell Receptor (BCR), the 
main types of lymphocytes, T cells and B cells, surface receptors that recognize antigens, are 
activated to initiate an immune reaction in response to the specific binding of their receptors to 
antigens such as tumours and viruses (Gagnaire et al., 2017).  
Therefore, in this project it will be analysed whether there is a certain relationship between the 
bacteria and some of the variables in the MetadataBCLA_RNA database, while studying and 
modelling the behaviour of the 0 values. One of the problems with the MetadataBCLA_RNA 
database was the large number of missing data contained in some variables, so the first step was 
to calculate the percentage of missing in each variable (Table 2, Figure 5). As a result of Figure 
4, it was found that depending on the origin of the variable (if it is a genetic expression, an immune 
system response, …) it presented the same percentage of lost values but not in the same subjects: 
Figure 5. Matrix Graph of missing and observed values, by rows. In the X axis are reflected the 433 subjects of the database 
and in the Y axis some of the variables, the red lines show the missing values that each one of the subjects has in the variables. 
Image created with the VIM package of the RStudio software. 
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In the first 18 variables, which are different variables of gene expression, it can be seen that it is 
always the same subjects who present NA (the red lines), but as soon as one passes to variables 
related to the immune system or environmental factor, the subjects who presented NA in the first 
variables no longer present it in the rest of the variables. Therefore, it is not always the same 
subjects who present NA throughout the entire database. 
Table 2. Summary table listing the name of the variable and the percentage of missing values it has in total. The complete table 
can be found in Annexes, page 9. 
 
 
 
 
 
 
 
 
 
 
An attempt was made to carry out a missing pattern to analyse whether these were MAR, MNAR 
or MCAR type, but due to the large number of variables this was very complicated or almost 
impossible to analyse. Finally, we chose to select those variables that had the lowest percentage of 
missing values and that allowed us to study (from all approaches) the behaviour of the 0-values, 
as it is a methodological project, all possible cases will be studied: quantitative variables with NA 
and without NA, categorical variables with two or more levels, with NA and without NA (Table 
3). 
The imputation of the variable Body Mass Index (BMI) was carried out, due to the good results 
obtained when using the predictive mean matching technique (Annexes, page 12). For each 
missing entry, the method forms a small set of donor candidates from all the complete cases that 
have predicted values closest to the predicted value for the missing entry. A donor is randomly 
drawn from the candidates and the observed donor value is taken to replace the missing value. The 
distribution of the missing cell is assumed to be the same as the observed data for the candidate 
donors (Schenker & Taylor, 1996). Once the values have been allocated, they are categorized into 
four different levels, according to the subject's kilograms: Underweight (BMI is less than 18.5) -  
Normal weight (BMI is 18.5 to 24.9) - Overweight (BMI is 25 to 29.9) – Obese (BMI is 30 or 
more). 
exprCHUK -0.389 1.113 1.281
exprCXCL8 -0.415 1.329 0.537
… … … …
TCGA.Subtype BLCA.2 - -
Stromal.Fraction 0.4 0.051 0.371
Proliferation 0.559 0.274 0.595
… … … …
BCR.Evenness 0.884 0.051 0.125
BCR.Richness 9 1555.325 31
… … … …
BMI 24.919 41.342 6.643
46.189
46.028
…
14.319
4.389
…
65.589
2.541
3.234
…
Variable
Percentage of missing 
values (%NA)
Median Var IQR
4.389
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Table 3. Summary table of selected variables. The following table shows the variables that have been selected to carry out the 
models. 
The workflow that will be carried out to be able to determine all the established hypotheses and 
study the behaviour of the 0 values, will be the following (Figure 6): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
exprTLR7 Numerical -0.336 5.719 0.659
exprMAP3K7 Numerical -0.458 1.605 1.352
exprNOD1 Numerical 0.009 1.885 0.866
Leukocyte.Fraction Numerical 0.202 0.027 0.233
Immune. Subtype Categorical
Tumor. Stage Categorical
Gender Categorical
BMI Categorical
3.233
0.462
0
0
C1, C2, C3, C4, C6
Stage i, Stage ii, Stage iii, Stage iv
Male, Female
Under, Normal, Overweight, Obese
IQR
4.389
4.389
0
4.389
Category levels
Variable type
Percentage of missing 
values (%NA)
Variable Median Var
Figure 6. Workflow. These are the steps that will be carried out to meet the main objective of the work. Image created in 
Biorender.com 
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As mentioned at the beginning of section 6 (6. Application to a real database), Kraken Counts 
Dataset contains 4,263 bacteria, and each of these behaves differently in different subjects. If 
density plots are made of these bacteria (Figure 6), it can be seen that they are different from each 
other, and that each one of them has a different number of zeros. While there are bacteria that have 
a high percentage of zeros and have a high total positive count (as is the case of Streptococcus 
mitis, which has 76.7% zeros and 23.3% positive values, corresponding to a total of 417 positive 
values); there are others that are just the opposite, a high percentage of zeros and a low total 
positive count (as is the case of Muricauda ruestringeis which has 99.9% zeros and 0.1% positive 
values, corresponding to a total of 3 positive counts). 
Figure 7. Density graph of some of the bacteria in Kraken's database. These three bacteria are taken at random from the 
document showing the density graphs of all the bacteria; the title indicates the name of the bacteria and below the graph, the 
number of 0's it contains. Image created with the ggplot2 package of the RStudio software. 
As it is specified in Section 3.1. Models for count data with excess of zeros and 3.2. Models for 
count data without excess of zeros, depending on the number of zeros in the variable, one method 
or another is applied. The main question is from what percentage of zeros it can be considered an 
excess of zeros. The authors working in this field are always referring to an excess of zeros, but 
they do not specify which is the cut-off point. So, the first key point is to determine, which bacteria 
have an excess of zeros and which do not.   
Instead of establishing a cut-off point, which was not based on any scientific evidence, a clustering 
approach was proposed so that those bacteria with more similar counts would be grouped together. 
The proposed clustering method is k-means algorithm which allows to group, since it allows to 
group objects into 𝑘 groups based on their characteristics. The grouping is done by minimizing the 
sum of distances between each object and the centroid of its group or cluster. Before carrying out 
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the algorithm, two different tools will be applied to calculate the optimal number of clusters into 
which the database would be divided: 
 The Elbow Method (Figure 8) is one of the most popular methods for determining this 
optimum value from a range of k-values. This approach plots the value of the cost function 
produced by different k-values, this function decreases as k increases, represented as the 
Total Sum of Squares: 
 
 
 
 
 
 
 
 
 
Figure 8. Elbow method. In this graph on the Y axis the Total within sum of square and on the X axis the number of k 
clusters. Graph created with the "factoextra" and "NbClust" packages of the RStudio software. 
 The Silhouette Method (Figure 9) measures of how similar an object is to its own group 
compared to other groups. Silhouette scores are in the range of [0, 1], a value of 1 indicates 
that the sample is far from its neighboring group and very close to the assigned group and, 
a value of 0 means that the distance between groups is equal.  
 
 
 
 
 
 
 
 
 
Figure 9. Silhouette method. In this graph on the Y axis the average silhouette width is indicated and on the X axis the 
number of k clusters. Graph created with the "factoextra" and "NbClust" packages of the RStudio software. 
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As it can be seen the optimal number of clusters is 2 in the Elbow Method, from that point the 
increment is almost null, and in the Silhouette Method the maximum score is reached with two 
clusters, which would indicate that the sample is well grouped and assigned to a highly appropriate 
group. 
Once the optimal number of clusters has been checked, the k-means algorithm is carried out 
(Figure 10), where two different groups can be observed. The blue cluster contains 4,257 bacteria 
and the pink cluster contains only 6. If the number of zeros in each of the bacteria in each group is 
analyzed, it can be seen that the bacteria with and without an excess of zeros, have been 
automatically brought together. This step is crucial to identify which methodology is used in each 
case. 
Figure 10. K-Means Clustering. The blue cluster contains all the variables with excess of zeros and the pink cluster, those that do 
not have this characteristic. Graphic created with the "NbClust" package of the RStudio software. 
For example, some of the bacteria in the pink cluster do not even have a single zero, e.g. 
Cutibacterium acnes or Klebsiella pneumoniae, and others have 12.24% of zeros, as 
Staphylococcus simulans (which contains the highest percentage of zeros in the pink cluster). 
While in the blue cluster more than 1,000 bacteria only contain zeros, another 2,017 bacteria have 
99% ~ 98% of zeros. Most bacteria are characterized by more than 70% of zeros. 
From now on, different methodologies will be applied to each group.  For the blue cluster we will 
use the appropriate methods for dealing with excess zeros (Zero Inflated Model and Zero Hurdle 
Model). For the pink cluster it will be use methods that do not work with this characteristic 
(DESeq2 and General Linear Models). 
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6.1. Cluster with excess zeros: 
 
In this section the group with excess zeros will be analysed in order to determine if the abundance 
of any bacteria is related to any environmental or genetic factor; therefore, as a dependent variable, 
the different bacteria in the Kraken Counts database will be taken, and as independent variables, 
the variables selected in MetadataBCLA_RNA (Table 3).  Both Zero-Inflated and Zero-Hurdle 
models are implemented in RStudio. In this work it will be used the “pscl” package (Zeileis at al., 
2008). The total count read to create the offset is taken. In Frame 1 it shows the R-code used to fit 
these models (all the databases are sorted by the subject ID):  
#Create the offset with the total reads of bacteria from the Kraken   
count dataset: 
clst2$Offset <- log(totalReadsKraken$nonHumanReads) 
# The first part of the formula (Kraken) displays the bacteria and the 
second (metadata) the covariates: 
fm < - formula (Kraken[, i] ~  metadataBCLA_RNA[,j] + offset(Offset)) 
Frame 1 
 
TotalReadsKraken contains the total read counts and belongs to the same individuals found in 
Kraken Count Database and in MetadataBCLA_RNA. The zero-inflated models will come by, 
Frame 2: 
ZIP < - zeroinfl(formula = fm, dist = "poisson", link = "logit", data 
 = metadataBCLA_RNA) 
ZINB <- zeroinfl(formula = fm, dist = "negbin", link = "logit", data  
 = metadataBCLA_RNA) 
Frame 2 
 
The dist option specifies the distribution for the count data. The link = logit option specifies the 
logistic link. The same formula as the previous ZIP and ZINB models are used to adjust the ZHP 
and ZHNB models using the hurdle() function, Frame 3: 
 
ZHP <- hurdle(formula = fm, dist= "poisson", data = metadataBCLA_RNA) 
ZHNB <- hurdle(formula = fm, dist= "negbin", data = metadataBCLA_RNA) 
Frame 3 
 
Figure 11, shows the distribution of zeros of the dataset. Scenarios are shown in which one will 
study how zeros behave, which distribution/model fits best and from which percentage of zeros 
and counts one starts to have reliable results. In each of the different scenarios, a bacterium (that 
meets the conditions described) will be used to carry out the examples: 
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Figure 11. Kraken dataset zero distribution. This diagram shows the percentage of zeros that this database has, and the number 
of bacteria that are characterized by it. Graph created in Biorender.com. 
 
I. Bacteria with 100% zeros 
 
In Kraken Count dataset, there are a total of 1,253 bacteria containing only zeros, Rhodococcus 
pyridinivoras is one of the bacteria that meets this condition. When some bacterium with 100% 
zeros is introduced into the models, as a dependent variable, the model has no sense. Therefore, 
all those bacteria with 100% zeros are removed from the database. 
 
II. Bacteria with 99.9% ~ 98% zeros 
 
The Kraken Counts dataset, contains 2,017 bacteria with 98% to 99.9% zeros, therefore, in this 
item, several cases will be studied (in all models it will be used, as an independent variable, the 
leukocyte fraction): 
 
 Case 1: bacteria with 432 zeros and a total of 3 positive counts. 
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Muricauda ruestringensis contains 432 zeros, and one subject has 3 counts of this bacterium: 
𝔼𝑀.𝑅𝑢𝑒𝑠𝑡𝑟𝑖𝑛𝑔𝑒𝑛𝑠𝑖𝑠 = 0.007,         𝕍𝑎𝑟𝑀.𝑅𝑢𝑒𝑠𝑡𝑟𝑖𝑛𝑔𝑒𝑛𝑠𝑖𝑠 = 0.021,         ℂ𝕍𝑀.𝑅𝑢𝑒𝑠𝑡𝑟𝑖𝑛𝑔𝑒𝑠𝑖𝑠 = 2081.63% 
 
The variation has been found to be larger than the expected value of the data, indicating a clear 
over-dispersion. In addition, such a high coefficient of variation (CV) is indicating that the data 
are highly variable, i.e., they are "heterogeneous" and highly dispersed. If a Zero Inflated Model 
is used, these models do not yet converge due to the large number of zeros in the data; if a Zero 
Hurdle Model is used, happens again as in the previous scenario: the model still does not converge. 
Therefore, with 99.9% of zeros and such low positive counts, no valid results are obtained either. 
Bacteria with these characteristics are also eliminated from the database.  
 
 Case 2: bacteria with 432 zeros and a total of 358 positive counts. 
 
The next scenario to be contemplated is a bacterium with the same percentage of zeros as the 
previous one but with a much higher number of positive counts, as is the case of Chamaesiphon 
minutus with 432 zeros and 358 counts: 
 
𝔼𝐶.𝑀𝑖𝑛𝑢𝑡𝑢𝑠 = 0.827,                  𝕍𝑎𝑟𝐶.𝑀𝑖𝑛𝑢𝑡𝑢𝑠 = 295.991,              ℂ𝕍𝐶.𝑀𝑖𝑛𝑢𝑡𝑢𝑠 = 2080.87% 
 
In this case the variance is much higher than the expected value of the data, indicating a high over-
dispersion of the data. This CV is very similar to the coefficient of the previous case, so it would 
be interpreted in exactly the same way: the data are highly dispersed, they are "heterogeneous". 
 
This time the zero inflated models do converge but give the same "error" as the zero hurdle model: 
they still estimate missing values. Therefore, although both models converge, they do not give 
valid results, so regardless of the number of positive counts these bacteria have, those with 99.9% 
of zeros are eliminated from the database. 
 
 Case 3: bacteria with 429 zeros and a total of 43 positive counts. 
 
It continues to choose a bacterium with a lower percentage of zeros, Streptococcus parauberis, 
with 429 zeros (99%) and a total of 43 counts: 
 
𝔼𝑆.𝑃𝑎𝑟𝑎𝑢𝑏𝑒𝑟𝑖𝑠 = 0.099, 𝕍𝑎𝑟𝑆.𝑃𝑎𝑟𝑎𝑢𝑏𝑒𝑟𝑖𝑠 = 2.784,    ℂ𝕍𝑆.𝑃𝑎𝑟𝑎𝑢𝑏𝑒𝑟𝑖𝑠 = 1680.20% 
As in the previous contexts, the data still show overdispersion, with the difference that the CV is 
lower than that of the previous bacterium, although the interpretation is the same: the data are still 
highly dispersed, they are clearly "heterogeneous". 
Again, the models are carried out, with the difference that for the first-time results are obtained in 
the count model coefficients section, so that from this percentage of zeros valid results are obtained 
for the models: 
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 Zero Inflated Poisson model: (Output 1 – Annexes, page 14) 
 
 Zero Inflated Negative Binomial: (Output 2 – Annexes page 14) 
 
 Zero Hurdle Poisson model: (Output 3 – Annexes page 15) 
 
 Zero Hurdle Negative Binomial model: (Output 4 – Annexes page 15)  
 
By default, Outputs 1 to 4 show estimated coefficients, standard errors, values for the Wald test 
and associated p-values, but no confidence intervals. As a main observation, the zero component 
has not only the estimated parameters different in magnitude, but also their signs reversed. The 
difference sings between Zero Inflated Model and Zero Hurdle Model is due to the hurdle() 
function modelling the probability of a non-zero count, instead of the probability of a zero count. 
 The model selection criteria are carried out (Table 4), before establishing which model is best 
(applying the Vuong test), define which distribution best fits the data, if a Poisson or a Negative 
Binomial, using the AIC and BIC criteria along with the Likelihood Ratio Test (the lower value 
will indicate which distribution the data best fit): 
 
Table 4. Model comparison based on AIC, BIC and likelihood ratio test. In this table, the results for the AIC and BIC criteria 
and the result of the likelihood ratio test (LHRT) are shown for each of the above models, with the Streptococcus parauberis 
bacteria and the covariate Leukocyte. Fraction. 
 
 
 
 
 
 
 
 
As has been proven, the distribution that best fits the data is the Negative Binomial. A very 
important point to consider, is the Output 2 and Output 4 of each of these models and how it would 
be interpreted. The correct parameter interpretation should be based on the model definitions. As 
defined, the logistic component in the Zero Inflated Models corresponds to inferences about the 
outliers and structural zero groups; in the contrast, the logistic component in the Zero Hurdle 
Model correspond to inferences about zeros, in general (Section 4.1. Models for count data with 
excess of zeros). The parameters from the count component can be elaborated this way: for the 
log-linear component in the Zero Inflated model, parameters are interpreted with respect to the 
non-outlier and non-structural zero group, whereas for the Zero Hurdle model they are interpreted 
with respect to the non-zero group. In ZINB, it find that the log odds of being in the non-structural 
zero group (those who can have counts S. Parauberis) decrease with 7.142; on the level of the 
odds this means a decrease by 𝜇𝑖 = exp(−7.142) = 0.00079. For the count component of the 
ZHNB model (that is, parameter estimates conditioned on a subject having a positive count of S. 
Parauberis the probability of having at least one positive count of S. Parauberis is, 𝜇𝑖 =
Models AIC BIC LHRT
ZIP 96.874 113.157
ZINB 76.747 97.101
ZHP 96.997 113.280
ZHNB 76.484 96.838
ZINB
ZHNB
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exp(−5.3305) = 0.0048. Following the previous result (Table 4), the two finalist models are 
evaluated with the Vuong test (Outcome 5): 
Outcome 5 
 
The null hypothesis testing by Vuong test is that both models are indistinguishable. Based on the 
p-value, it is concluded that there is not enough evidence to reject it. Because the Vuong test does 
not determine which model is better, the residuals and Rootogram of each of the models are 
analysed (Figure 12): 
 
Figure 12. Q-Q Residuals Plot and Rootogram Zero Hurdle Negative Binomial model.  In the graph on the left are the 
conditional Pearson residues and, on the right, the Rootogram. The Q-Q Residuals Plot has been created with the "stats" 
package and the Rootogram with the "countreg" package of the RStudio software. 
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As explained in section 3.2. Model Selection, in the Rootograms the line at 0 allows us to easily 
visualize where the model is over- or under-fitting, so at 0 it fits perfectly by design. In the first 
counts of the Zero Inflated model we see a mismatch (below the line), which does not occur in the 
Zero Hurdle model.  
Both Q-Q Plots are checked to see if they fit the line correctly and are between -2 and 2, confirming 
the hypothesis of normality of the residuals but at the right end of the Zero Inflated model it can 
be seen how the residues "move away" from the line. Therefore, through these graphs, it was 
concluded that the Zero Hurdle Model fits the data better. In addition, there is scientific evidence 
that the barrier model is better in terms of microbiome data (since it does not differentiate between 
zero types and has greater convergence power than zero inflated model), which is just what was 
determined with the previous Outputs and plots. If all the models are performed again but using 
another type of covariate such as the expression of a certain gene, the gender of the subject, etc., 
the Vuong test provides the same result.  
 
If the independent variable is a two level categorical variable, such as gender, the models does 
return a result. However, if the covariate has more than two levels, such as Immune. Subtype, 
Tumor_stage and BMI, there is more than one category that includes only zeros and the standard 
error cannot be estimated (Table 5): 
 
Table 5. Cross table of S. Parauberis with Immune Subtype. This table shows each of the categories of this covariate and the 
number of zeros and counts that each of them containss 
 
 
 
 
 
No significant result is obtained for the Zero Hurdle Model coefficients part and for the count 
model coefficients section, since the number of counts per category is so low of positive values 
and more than one contains only zeros, the error cannot be estimated, neither the Z-value or the p-
value. 
 
 Case 4: bacterium with 423 zeros and a total of 154 positive counts. 
Sneathia amnii has a 98% zeros, and 2% positive counts (154 total positive values), in order to 
check if the Vuong test gives different results in relation to which model to work with and if the 
categorical variables with more than two levels give results in the models: 
 
𝔼𝑆.𝐴𝑚𝑛𝑖𝑖 = 0.356,                   𝕍𝑎𝑟𝑆.𝐴𝑚𝑛𝑖𝑖 = 46.609,                    ℂ𝕍𝑆.𝐴𝑚𝑛𝑖𝑖 = 1919.57% 
 
Again, the models are made with Leukocyte Fraction as a covariate, and the same conclusions are 
reached as for the previous bacterium, which contained a higher percentage of zeros (Table 6): 
 
S.Parauberis C1 C2 C3 C4 C6 NA
Zero 184 169 22 37 3 14
Positive count 0 3 0 1 0 0
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Table 6. Model comparison based on AIC, BIC, likelihood ratio test and Vuong test. In this table, the results for the AIC and BIC 
criteria and the result of the likelihood ratio test are shown for each of the above model, with Sneathia amnii bacteria and the 
covariate Leukocyte. Fraction.  
 
 
 
 
 
The Vuong test returns the same result as before, both models fit equally well, but always using a 
binomial negative distribution as the data are over-dispersed. The zero-hurdle model is chosen 
because it does not distinguish between zeros and is recommended for working with microbial 
data (besides being the model with the lowest AIC and BIC).  The model is presented in Output 6: 
Output 6 
Interpretation: (Zero-hurdle model) For those subjects with minimal values in the Leukocyte 
Fraction, the probability of having a positive count of Sneathia amnii is 0.012: 
𝑃(𝑆. 𝐴𝑚𝑛𝑖𝑖 ≥ 1̂ |𝑚𝑖𝑛𝐿𝑒𝑢𝑘𝑐𝑦𝑡𝑒 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛) =
𝑒−4.4209
(1 + 𝑒−4.4209)
= 0.0118 ~ 0.012 
(Positive count model) For each 0.1 increase in the Leukocyte Fraction, there is a 
(𝑒61.86 ∗0.1 = 485.9) 485.9 increase in the Sneathia amnii rate. The theta count confirms that the 
data does present over-dispersion. So the link function (taking into account Equations 10 and 11) 
would look like this: 
 For the logistic regression: 
 (
𝑝𝑗
1 − 𝑝𝑗
) = 𝑒−4.4209 = 0.012 
Models AIC BIC LHRT Vuong test
ZIP 900.104 916.387
ZINB 136.834 157.187
ZHP 901.028 917.311
ZHNB 132.400 152.754
ZINB
ZINB/ 
ZHNB
ZHNB
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 For the truncated model, which will be given with an increase in 𝜇𝑗:  
(𝜇𝑗) = 𝑒
61.86 ∗ 𝐿𝑒𝑢𝑘𝑜𝑐𝑦𝑡𝑒. 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 = (7.336 ∗ 1026) ∗ 𝐿𝑒𝑢𝑘𝑜𝑐𝑦𝑡𝑒. 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛  
The model residuals and Rootogram are shown below (Figure 13): 
 
Figure 13. Q-Q Residuals Plot and Rootogram zero hurdle Negative Binomial model.  In the graph on the left are the conditional 
Pearson residues and, on the right, the Rootogram. The Q-Q Residuals Plot has been created with the "stats" package and the 
Rootogram with the "countreg" package of the RStudio software. 
 
In the Q-Q residues graph, it is checked that these fit correctly to the line and are between -2 and 
2, confirming the hypothesis of normality of the residues. In the Rootogram it is observed that the 
expected values (the red line) fit correctly to the observed values, so it could be concluded that the 
model fits correctly the data. 
 
From this last block it can be concluded that from 99% of zeros, the Zero Inflated model and the 
Zero Hurdle Model do converge, so that percentage is assumed as a cut-off point through which 
statistically significant results begin to be obtained. 
 
III. Bacteria with 97.9% ~ 95% zeros 
 
To check if, with a lower percentage of zeros, categorical covariates with more than two levels can 
be correctly estimated in the model and if the Vuong test still gives the same result as in the 
previous cases, different cases will be shown again: 
 
 Case 1: bacterium with 420 zeros and a total of 20 positive counts:  
 
The first bacteria to be used is Filifactor alocis, with a total of 420 zeros (96.99% zeros) and 20 
total counts: 
 
𝔼𝐹.𝐴𝑙𝑜𝑐𝑖𝑠 = 0.0462,               𝕍𝑎𝑟𝐹.𝐴𝑙𝑜𝑐𝑖𝑠 = 0.146,                  ℂ𝕍𝐹.𝐴𝑙𝑜𝑐𝑖𝑠 = 827.27% 
 
In this case the models will be carried out using two-level categorical variables, i.e. Filifactor 
alocis  ~ 𝛽0 + 𝛽1 ∗ 𝐺𝑒𝑛𝑑𝑒𝑟 + 𝑜𝑓𝑓𝑠𝑒𝑡; and categorical variables with 5 levels and missing values: 
Filifactor alocis  ~ 𝛽0 + 𝛽1 ∗ 𝐼𝑚𝑚𝑢𝑛𝑒. 𝑆𝑢𝑏𝑡𝑦𝑝𝑒 + 𝑜𝑓𝑓𝑠𝑒𝑡. Before carrying out the models, the 
zeros and positive counts for each covariate are determined (Table 7 and 8): 
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Table 7. F. Alocis bacterium with Gender. This table shows each of the categories of this covariate and the number of zeros and 
counts that each of them contains.  
 
 
 
 
 
Since all categories of the covariate "gender" have positive counts, the results of all models can be 
estimated and compared (Table 8): 
 
Table 8. Model comparison based on AIC, BIC, likelihood ratio test and Vuong test. In this table, the results for the AIC and BIC 
criteria and the result of the likelihood ratio test are shown for each of the above models, with Filifactor alocis bacteria and the 
covariate “Gender”. 
 
 
 
 
 
 
 
Again, the same conclusions as Block II are obtained: the distribution that best fits the data is the 
Negative Binomial, due to the over-dispersion that the variable shows; the data is adjusted to a 
Zero Hurdle Model (Output 7):  
Output 7 
 
In the Zero-hurdle model coefficients, the probability (for a woman) of having at least 1, Filifactor 
alocis is 0.026: 
𝑃(𝐹. 𝐴𝑙𝑜𝑐𝑖𝑠 ≥ 1|𝑊𝑜𝑚𝑒𝑛̂ ) =
𝑒−3.6463
(1 + 𝑒−3.6463)
= 0.0258 ~ 0.026 
 
F.Alocis Male Female
Zero 307 115
Positive count 8 3
Models AIC BIC LHRT Vuong test
ZIP 149.985 166.268
ZINB 149.972 170.325
ZHP 148.261 164.544
ZHNB 145.128 165.481
ZINB
ZINB/ 
ZHNB
ZHNB
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If, for example, we wanted to calculate the probability of having a positive count for a man on 
Filifactor alocis, it would add to the value of e the man's intercept plus the woman's. 
So the link function (taking into account Equations 11) would look like this: 
 For the truncated model, there would be an increase in 𝜇𝑗 of:  
(𝜇𝑗) = 𝑒
−3.6463  
Because the other coefficients are not statistically significant, none of these can be concluded. A 
low theta value confirms that the data is over dispersed.  
 
As in previous scenarios, the model residuals and Rootogram are studied (Figure 14): 
 
Figure 14. Q-Q Residuals Plot and Rootogram zero hurdle Negative Binomial model.  In the graph on the left are the residues 
and, on the right, the Rootogram. The Q-Q Residuals Plot has been created with the "stats" package and the Rootogram with the 
"countreg" package of the RStudio software. 
 
In the Q-Q residuals plot, it is checked that these fit correctly to the line and are between -2 and 2, 
confirming the hypothesis of normality of the residues. In the Rootogram it is observed that the 
expected values (the red line) fit well to the observed values, so it could be concluded that the 
model fits correctly to the data.  
 
Applying this same model to the Immune subtype variable, it is verified that, presenting 0 positive 
counts in certain categories and such low positive counts in others (Table 9), the model returns 
missing values in the count model coefficients part. 
 
Table 9.  Cross table of F. Alocis bacterium with Immune Subtype. This table shows each of the categories of this covariate and 
the number of zeros and counts that each of them contains. 
 
   
 
 Case 2: bacterium with 413 zeros and a total of 308 positive counts. 
F.Alocis C1 C2 C3 C4 C6 NA
Zero 179 169 21 36 3 12
Positive count 5 3 1 2 0 2
Study of the distribution and behaviour of the “0” values in large omic data arrays                                     Helena Fidalgo Gómez  
  
40 
 
Leuconostoc mesenteroides, which has fewer zeros and a higher total count than the previous 
bacterium: 
𝔼𝐿.𝑀𝑒𝑠𝑒𝑛𝑡𝑒𝑟𝑜𝑖𝑑𝑒𝑠 = 0.711, 𝕍𝑎𝑟𝐿.𝑀𝑒𝑠𝑒𝑛𝑡𝑒𝑟𝑜𝑖𝑑𝑒𝑠 = 123.812,    ℂ𝕍𝐿.𝑀𝑒𝑠𝑒𝑛𝑡𝑒𝑟𝑜𝑖𝑑𝑒𝑠 = 1564.27% 
 
Again, it will be analysed which model fits better, this time using a covariate containing NA, to 
confirm that with this percentage of zeros and with a covariate with missing values, the Vuong test 
still returns the same result; the selected covariate is the expression of TLR7 with 4.39% of missing 
values (Table 10): 
Table 10. Model comparison based on AIC, BIC, likelihood ratio test and Vuong test.  
 
 
 
 
 
 
 
 
Where the Vuong test returns (as in the previous cases) that both models fit equally well; the 
residuals and the Rootogram of both models are studied again to ensure the test result (Figure 15): 
 
Figure 15. Q-Q Residuals Plot and Rootogram for zero inflated Negative Binomial model and zero hurdle Negative Binomial 
model.  In the graph on the left are the residues and, on the right, the Rootogram. The Q-Q Residuals Plot has been created with 
the "stats" package and the Rootogram with the "countreg" package of the RStudio software. 
Models AIC BIC LHRT Vuong test
ZIP 1864.285 1880.389
ZINB 247.099 267.228
ZHP 2634.575 2650.678
ZHNB 550.921 571.050
ZINB
ZINB/ 
ZHNB
ZHNB
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Where it can be seen that for both models the residue graph is practically the same, and that they 
fit correctly to line in a limit between 2 and -2, indicating the normality of these. The main 
difference between these two graphs can be found at the far right, where the ZINB model residues 
are "moving away" from the line. Something that also happened in the Figure 11.  
On the other hand, the Rootograms are different for each of the models, the curve of the Rootogram 
for the ZHNB model is much smoother and fits better to the observed data than in the Rootogram 
for ZINB.  
 
Therefore, it is assumed that the data fits better in a Zero-Hurdle model; the result of this is (Output 
8): 
Output 8 
Interpretation: (Zero-hurdle model) For those subjects with minimal values of TLR7 gene 
expression, the probability of having a positive count of Leuconostoc mesenteroides is 0.05: 
𝑃(𝐿.𝑀𝑒𝑠𝑒𝑛𝑡𝑒𝑟𝑜𝑖𝑑𝑒𝑠 ≥ 1̂ |𝑚𝑖𝑛𝐸𝑥𝑝𝑟𝑇𝐿𝑅7) =
𝑒−2.99132
(1 + 𝑒−2.99132)
= 0.0478 ~ 0.05 
 
(Positive count model) For each 1-unit increase in the "Z-Score", of the TLR7 gene expression, 
there will be a (𝑒3.582 = 35.945) 36 increase in the average abundance of Leuconostoc 
mesenteroides.  
The theta count confirms that the data does present over-dispersion. So the link function (taking 
into account Equations 10 and 11) would look like this: 
 
 For the logistic regression: 
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 (
𝑝𝑗
1 − 𝑝𝑗
) = 𝑒−2.99132 
 For the truncated model, there will be an increase in 𝜇𝑗:  
(𝜇𝑗) = 𝑒
3.582 ∗ 𝐸𝑥𝑝𝑟. 𝑇𝐿𝑅7 = 35.945∗ 𝐸𝑥𝑝𝑟. 𝑇𝐿𝑅7 
It can be concluded that the Vuong test still gives the same results, and that the zero hurdle models 
give better results than the zero inflated models. For the categorical variables with more than two 
levels, it is still not possible to have results due to the high percentage of zeros that the bacteria 
still present. 
 
IV. Bacteria with 94.9% ~ 70% zeros 
Only one bacterium will be studied that has enough positive counts to carry out the models with 
categorical variables of more than two levels, without returning lost values in the results of the 
models: Streptococcus mitis. 
𝔼𝑆.𝑀𝑖𝑡𝑖𝑠 = 0.963,                   𝕍𝑎𝑟𝑆.𝑀𝑖𝑡𝑖𝑠 = 85.948,                 ℂ𝕍𝑆.𝑀𝑖𝑡𝑖𝑠 = 962.65% 
As in the other cases that have been shown, the variance is much greater than the expect- value 
and the coefficient of variation is still extremely high, indicating a clear dispersion of the data. The 
first covariate with which the model will be made is "Tumor_Stage", which has 4 levels and none 
of these contain only zeros, so the model can be carried correctly (Table 11): 
Table 11.  S. Mitis bacterium with Stage Tumour. This table shows each of the categories of this covariate and the number of 
zeros and counts that each of them contains. 
 
 
 
A comparison between the 4 plausible models is shown below (Table 12): 
 
Table 12. Model comparison based on AIC, BIC, likelihood ratio test and Vuong test. In this table, the results for the AIC and 
BIC criteria and the result of the likelihood ratio test are shown for each of the above models, with Streptococcus mitis bacteria 
and the covariate “Tumor_stage”. 
 
 
 
 
 
The Vuong test returns the same result as in previous cases (ZINB/ ZHNB, both models are valid) 
so the residuals and Rootograms of the finalist models, ZINB vs. ZHNB, are studied, in order to 
select the one that best fits the data (Figure 16): 
Models AIC BIC LHRT Vuong test
ZIP 2450.670 2483.199
ZINB 827.702 864.297
ZHP 2438.233 2470.761
ZHNB 796.060 832.655
ZINB
ZINB/ 
ZHNB
ZHNB
S. Mitis Stage i Stage ii Stage iii Stage iv NA
Zero 2 104 111 115 0
Positive count 2 30 38 29 3
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 Figure 16. Q-Q Residuals Plot and Rootogram for zero inflated Negative Binomial model and zero hurdle Negative Binomial 
model.  In the graph on the left are the residues and, on the right, the Rootogram. The Q-Q Residuals Plot has been created with 
the "stats" package and the Rootogram with the "countreg" package of the RStudio software. 
In both models the residuals are very similar and fit correctly to the line between 2 and -2, thus 
fulfilling the hypothesis of normality of the residuals. The Rootograms of the models are different, 
it can be seen that the expected data (the red line) fits better to the data observed in the zero-hurdle 
model, so this model is selected as the final model; the results are (Output 9 – Annexes page 16):  
 
There are no results that are statistically significant, the theta count confirms the over-dispersion 
of data. 
 
In all the blocks/scenarios where the number of zeros and the number of positive counts were 
studied (regardless of the covariate used to carry out the models), the model that best fitted the 
zeros was the Zero Hurdle Model. This is a very important result since it will help us a lot when 
automating the whole database, in the articles that have been mentioned along the different 
sections, only one case was studied (a concrete percentage of zeros) but never with databases as 
big as the ones that are being applied here; when verifying that independently the percentage of 
zeros, the zero hurdle model works correctly it will be possible to automate all this much better.  
One advantage that needs to be mentioned is that the Zero Inflated Model and Zero Hurdle models 
is that, when considered as two-part models, different covariates can be used in each of those parts, 
for example, if the formula being declared contains "|" the parts of the model are being separated 
and it would have to be declared which covariate is going to be applied to each part of the model, 
Frame 4: 
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f1 <- formula (Leuconostoc mesenteroides ~ exprTLR7 + offset(Offset)   
            |exprTLR7) 
Frame 4 
In "f1" we would be stating that the covariate "ExprTLR7" is going to be applied in both parts of 
the model; this is a great advantage in multivariate models, since different covariates could be 
applied in different parts of the models. 
 
6.2. Cluster without excess zeros: 
 
In this other section, it is found the bacteria that do not present excess of zero, that it was found 
when making the k-means cluster with the Kraken Count database; as it is indicated in the 
following scheme (Figure 17), half of these do not even present zeros, and of those that present it 
will be analysed if they respond better to a normal GLM or if it is necessary to use more complex 
methods, as the previous models that have been used. In bacteria whose minimum count is not 
zero, these models clearly cannot be tested, since they do not present zeros. 
 
Figure 17. Kraken diagram. This diagram shows the percentage of zeros that this database has, and the number of bacteria that 
are characterized by it. Graph created in Biorender.com. 
 
In the case of bacteria such as Neisseria gonorrhoeae, Enterobacter cloacae or Staphylococcus 
simulans, there is a very low percentage of zeros and very high positive counts. When analysing 
the theory behind the Zero Inflated models and the Zero Hurdle models, it has been seen that the 
main difference between these models is that, while the Zero Inflated Model is based on a 
distribution with a mass function concentrated on zero, the Zero Hurdle Model differentiates 
between zeros and non-zeros and fits a model for each situation.  
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Clearly in this situation a Zero Inflated model cannot be carried out (since there is no excess of 
zeros), but a Zero Hurdle model can. Therefore, to check if the Zero Hurdle model works better 
than a GLM we will take a bacterium that has a low percentage of zeros: 
 Case 1: bacterium with 8 zeros and a total of 21,275 positive counts. 
Enterobacter cloacae, with 8 zeros (1.85%) and a total of 21,275 positive values, 
𝔼𝐸. 𝐶𝑙𝑜𝑎𝑐𝑎𝑒 = 49,134                  𝕍𝑎𝑟𝐸.𝐶𝑙𝑜𝑎𝑐𝑎𝑒 = 4925,  153                     ℂ𝕍𝐸.𝐶𝑙𝑜𝑎𝑐𝑎𝑒 = 142.83% 
The variation has been found to be larger than the expected value of the data, indicating a high 
over-dispersion. As the CV is less than 20% it indicates a high accuracy of the data and that the 
average is representative of the data set, therefore it is "homogeneous". The models are built 
exactly as before, the offset and the formula are the same, Frame 5: 
 
Offset <- log(totalReadsKraken$nonHumanReads) 
fm < - formula (E.Cloacae ~ Gender + offset(Offset)) 
Frame 5 
In this case it will be used as a covariate, gender, therefore the models to be studied are as follows, 
Frame 6: 
 
GLMNB <- glm.nb(fm, data = metadataBCLA_RNA)) 
GLMP <- glm (fm, family = "poisson", data = metadataBCLA_RNA)) 
ZHP <- hurdle (formula = fm, dist= "poisson", data = metadataBCLA_RNA) 
ZHNB <- hurdle (formula = fm, dist= "negbin", data = metadataBCLA_RNA) 
Frame 6 
The same model selection criteria that have been used in the previous blocks will be carried out 
(Table 13): 
Table 13. Model comparison based on AIC, BIC, likelihood ratio test and Vuong test. In this table, the results for the AIC and 
BIC criteria and the result of the likelihood ratio test are shown for each of the above models, with Enterobacter cloacae 
bacteria and the covariate “Gender”. 
 
 
 
 
 
Those models have lower values in the AIC and Bic criteria are the ones that uses a Negative 
Binomial distribution, and they are also the ones that select the Likelihood Ratio Test. The main 
difference, is that this is the first time that the Vuong test has selected a final model (Output 10): 
Models AIC BIC LHRT Vuong test
GLMP 49158.858 49167
GLMNB 4468.375 4480.587
ZHP 49118.059 49134.341
ZHNB 4412.751 4433.105
ZHNB
GLMNB
ZHNB
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Output 10 
In the Variance test, the p_value is statistically significant, so the alternative hypothesis that 
models are distinguishable is accepted. Since the models are distinguishable we will study which 
of the two models fits our data best in the Non-nested likelihood ratio test. We see that the 
hypothesis with a significant p_value is the H1B, so the Zero Hurdle Negative Binomial model 
(model 2), fits better than the GLM Negative Binomial (model 1). In addition, if the residuals and 
Rootograms of both models are compared (Figure 18): 
Figure 18. Q-Q Residuals Plot and Rootogram for GLM Negative Binomial model and Zero Hurdle Negative Binomial model.  In 
the graph on the left are the residues and, on the right, the Rootogram. The Q-Q Residuals Plot has been created with the "stats" 
package and the Rootogram with the "countreg" package of the RStudio software. 
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In both models the residuals are very similar and fit correctly to the line between 2 and -2, thus 
fulfilling the hypothesis of normality of the residuals, although in the zero hurdle model negative 
binomial model these fit much better to the line. If we analyse the Rootograms in the first counts 
of the GLM. Negative Binomial model we see a mismatch (over the line), which does not occur in 
the Zero Hurdle Negative Binomial model, in addition, in this model all bars are on the 0 line, 
while in the GLM model, many are being over/under fitting. The result of the ZHNB model is 
(Output 11): 
Output 11 
Interpretation: (Zero-hurdle model) The probability (for a woman) of having a positive count is 
0.985, and the probability (for a woman) of having a zero count is 0.015: 
𝑃(𝐸. 𝐶𝑙𝑜𝑎𝑐𝑎𝑒 ≥ 1|𝑊𝑜𝑚𝑎𝑛̂ ) =
𝑒4.0604
(1 + 𝑒4.0604)
= 0.9845 ~ 0.985 
The probability (for a male) of having a positive count is 1, and the probability (for a men) of 
having a zero count is 0, (the category is not significant, it is just an example of how it would be 
calculated): 
𝑃(𝐸. 𝐶𝑙𝑜𝑎𝑐𝑎𝑒 ≥ 1|𝑀𝑎𝑙𝑒̂ ) =
𝑒4.0604+18.5056
(1 + 𝑒4.0604+18.5056)
= 1 
 
(Positive count model) The mean frequency of Enterobacter cloace for a woman with mussel 
invasive bladder cancer is (𝑒−9.7614 = 0.00006), 0. The mean frequency of Enterobacter cloace 
for a male with mussel invasive bladder cancer is 1.60 times, the mean frequency of Enterobacter 
cloacae for a woman with the same type of pathology, holding the other variables constant. The 
theta count confirms that the data does present over-dispersion.  
Therefore, the link function (taking into account Equations 10 and 11) would look like this: 
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 For the logistic regression: 
 (
𝑝𝑗
1 − 𝑝𝑗
) = 𝑒4.0604 
 For the truncated model, there is an increase in 𝜇𝑗:  
(𝜇𝑗) = 𝑒
−9.7614 + 𝑒0.4702 ∗ 𝐺𝑒𝑛𝑑𝑒𝑟𝑀𝑎𝑙𝑒 = 0.01689  + 1.60∗ 𝐺𝑒𝑛𝑑𝑒𝑟𝑀𝑎𝑙𝑒 
With this, it is demonstrated that the Zero Hurdle model works better than a GLM, with data 
presenting any percentage of zeros, then it will show a bacterium that does not present any 0 where 
a GLM has to be applied. 
 Case 2: bacterium without zeros. 
Escherichia coli, with 0 zeros: 
𝔼𝐸. 𝐶𝑜𝑙𝑖 = 40,177                𝕍𝑎𝑟𝐸.𝐶𝑜𝑙𝑖 = 965,498                ℂ𝕍𝐸.𝐶𝑜𝑙𝑖 = 77.34% 
As the variance is much larger than the expected value, it will directly adjust to a negative binomial 
distribution, as the data are clearly over-dispersed. The models are built exactly as before, the offset 
and the formula are the same, Frame 7:  
Offset <- log(totalReadsKraken$nonHumanReads) 
fm1 <- formula (E.Coli ~ Immune.Subtype + offset(Offset)) 
GLMNB <- glm. nb(fm1, data = metadataBCLA_RNA)) 
Frame 7 
Using "Immune. Subtype" as a covariate, the result of the model is as follows (Output 12): 
Output 12  
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Interpretation: The presence of the C3 immune subtype increases the average Escherichia coli by 
𝑒0,60333 = 1,82%, this corresponds to a probability of: 
𝑝 =
𝑒0.60333
1 + 𝑒0.60333
= 0.646 ~ 0.65 
And the presence of the C4 immune subtype increases the average Escherichia Coli by 𝑒0.62953 =
1.88%, this corresponds to a probability of:  
𝑝 =
𝑒0.62953
1 + 𝑒0.62953
= 0.65  
The link function will remain (for C3 Immune subtype and C4 Immune subtype): 
𝑙𝑜𝑔𝑖𝑡(𝐸𝑠𝑐ℎ𝑒𝑟𝑖𝑐ℎ𝑖𝑎 𝑐𝑜𝑙𝑖) = −9.62737 + 0.60333 ∗ 𝐶3; 
𝑙𝑜𝑔𝑖𝑡(𝐸𝑠𝑐ℎ𝑒𝑟𝑖𝑐ℎ𝑖𝑎 𝑐𝑜𝑙𝑖) = −9.62737 + 0.62953 ∗ 𝐶4; 
Where the value of the probability of Escherichia coli can be obtained with the inverse of the 
natural logarithm: 
𝑝(𝐸𝑠𝑐ℎ𝑒𝑟𝑖𝑐𝑖ℎ𝑎 𝑐𝑜𝑙𝑖) =
𝑒−9.62737 + 𝑒0.60333 ∗ 𝐶3
1 + 𝑒−9.62737 + 𝑒0.60333 ∗ 𝐶3
; 
𝑝(𝐸𝑠𝑐ℎ𝑒𝑟𝑖𝑐𝑖ℎ𝑎 𝑐𝑜𝑙𝑖) =
𝑒−9.62737 + 𝑒0.62953 ∗ 𝐶4
1 + 𝑒−9.62737 + 𝑒0.66953 ∗ 𝐶4
; 
 
6.2.1. Example with DESeq2: 
 
As explained in Section 4.3. Models for counting data without excess of zeros, the example that 
will be shown below is within the DESeq2 package, which can be installed through 
"BiocManager": with the variance stabilization technique this package has the capacity to model 
microbial data with overdispersion and without excess of zeros (this method supports bacteria 
containing up to 15%~20% zeros), from the sequencing of the 16S RNA-seq. DESeq2 requires 
content data in the form of an integer value matrix as input data. These tables of contents are 
generated from RNA-Seq or other high throughput sequencing experiments.  
The example datasets consist of two parts: OTU-table, where the cluster will be used without 
excess zeros, and a meta-table, where metadata variables will be used. Both numerical and 
categorical covariates can be used, the main disadvantage of this method is that covariates 
containing missing values cannot be used. 
To explain how the analysis would be carried out, everything will be explained step by step, adding 
in each of these the code in RStudio: 
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1. Create the count table: the DESeq2 needs count data in the form of a rectangular table 
(matrix) of integer values as input data. The table cell in the i row and the j column of the 
table tells how many reads have been mapped to taxon i in sample j. Once it has the matrix, 
the DESeqDataSetFromMatrix() function is used to create a DESeq2 object, Frame 8. 
 
matrix_clst1<-as(clst1, "matrix") 
matrix_clst1<-(t(matrix_clst1)) 
Frame 8 
 
2. Select the metadata variable for the analysis: the metadata consists mainly of the sample 
information of our interest, here one selects a categorical or numerical variable that does 
not contain NA, for example “sample.type” from the metadataBCLA_RNA database, 
Frame 9: 
 
group_tumor<- metadata$Sample.Type 
head(group_tumor) 
factor_tumor <- data.frame(row.names=colnames(matrix_clst1),gro
up= 
group_tumor) 
head(factor_tumor,3) 
Frame 9 
3. Build the DESeq2 Object: the object class used by DESeq2 to store the read counts and 
estimated values during statistical analysis is the DESeqDataSet, which will generally be 
represented in the code as a “dds” object. A DESeqDataSet object must have an associated 
design formula; the design formula expresses the variables that will be used in the 
modeling. The formula must be a tilde (~) followed by the variables to be used. 
The DESeqDataSetFromMatrix function can be used if you already have a read count 
matrix prepared, with the count matrix matrix_clst1, and the colData sample information, 
we can build a DESeqDataSet, Frame 10: 
if (!requireNamespace("BiocManager", quietly = TRUE)) 
install.packages("BiocManager");  
BiocManager::install("DESeq2");library(DESeq2) 
dds <- DESeqDataSetFromMatrix (countData = matrix_clst1,       
colData = factor_tumor, design = ~ group) 
Frame 10 
 
In countData you define the matrix that contains the count data of the taxon, in colData 
the object that has been created in step 2 that refers to the subject and the category of 
"sample_type" that it has. With design (which refers to the formula) you are asked to make 
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a comparison by groups (Solid Tissue Normal vs. Primary Tumor). If for example a 
numerical variable had been selected without missing values (e.g. Leukocyte. Fraction), 
the code would be as follows, Frame 11: 
matrix_clst1<-as(clst1, "matrix") 
matrix_clst1<-(t(matrix_clst1)) 
V.M <- metadata$Leukocyte.Fraction 
data <- data.frame(row.names=colnames(matrix_clst1),var = V.M) 
dds <- DESeqDataSetFromMatrix(countData = matrix_clst1, colData
 = data, design = ~ var) 
Frame 11 
 
4. Estimate size factors: DESeq2 uses the “median ratio method” described in Anders and 
Huber (2010) to estimate the size factors. It first defines a virtual reference sample by 
taking the median of each taxa values across samples and then computes size factors as the 
median of ratios of each sample to the reference sample (Anders and Huber 2010). An 
offset is built in the statistical model of DESeq2, Frame 12. The estimated size factors can 
be accessed using the accessor function sizeFactors(). 
dds <- estimateSizeFactors(dds) 
sizeFactors(dds) 
Frame 12 
 
5. Estimate the Overdispersion: the first task in the analysis of abundance microbiome data 
is to estimate the dispersion parameter for each taxon. When a negative binomial model is 
fitted, the variability between replicates is modelled by the dispersion parameter. The 
function estimateDispersions() are used to estimate the dispersion parameters, Frame 13: 
print(dds<- estimateDispersions(dds)) 
Frame 13 
 
6. Extract the Results Table: before carrying out the model, we make sure that the factor 
variable is defined correctly: “Solid Tissue Normal” is the first level in the condition 
factor, so that the default log2 fold changes are calculated as “Primary Tumor” over 
“Solid Tissue Normal”, Frame 14: 
dds$group <- factor(dds$group, levels = c("Solid Tissue Normal",
       "Primary Tumor")) 
Frame 14 
DESeq2 conducts the differential expression analysis based on the Negative Binomial 
distribution. The workflow it carries out is as follows: (i). estimation of size factors, (ii). 
estimation of dispersion, (3). Negative Binomial GLM fitting and Wald statistics. After the 
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DESeq2 function returns a DESeqDataSet object, results tables (log2 fold changes and p-
values) can be generated using the results() function, Frame 15: 
dds <- DESeq(dds) 
(res <- results(dds)) 
Frame 15 
 
The result of this method is as follows (Output 13 – Annexes page 16): 
 
The main results are in baseMean, log2FoldChange and p-value: baseMean, is the average 
of the normalized count values, dividing by size factors, taken over all samples. The 
remaining four columns refer to a specific contrast: the comparison of the levels Primary 
Tumor vs. Solid Tissue Normal of the factor variable group. The column log2FoldChange 
is the effect size estimate. It tells us how much the OTU’s abundance seems to be different 
due to group with Primary Tumor in comparison to Solid Tissue Normal. This value is 
reported on a logarithmic scale to base 2. Those bacteria that are statistically significant, 
that is, that have a pvalue < 0.05, are: Cutibacterium acnes, Neisseria gonorrhoeae, 
Enterobacter cloacae and Klebsiella pneumoniae. 
 
If the GLM models are carried out for those bacteria without zeros and the Zero Hurdle Model for 
the rest, the same statistically significant bacteria are obtained as with the DESeq2 method. The 
main difference between applying the regression models and the method proposed by DESeq2, is 
that the different model selection methods proposed (AIC, BIC, Likelihood Ratio Test and Vuong 
test) cannot be applied to analyse which one best fits the original data. The main advantage is the 
output that this method returns, it is not necessary to select one by one the bacteria to carry out all 
the models, but it automatically analyses all the bacteria in the database and carries out all the 
models.  
 
7. Discussion and Final Conclusion: 
 
The analysis of microbiome data with excess zeros and overdispersion can be carried out with 
different methods: adapting regression models for count data with these characteristics, applying 
a normalization, and adjusting them to a Gaussian distribution, or using a compositional 
methodology. 
Current RNA-Seq-based standardization methods that have been adapted for microbiome data do 
not take into account the unique characteristics of microbiome data. L. Chen et al. in 2018 proposed 
a standardization method for this type of count data (with excess zeros and overdispersion) based 
on geometric mean of pairwise ratios. Normalization is especially critical when library size is a 
confounder that correlates with the variable of interest. An inappropriate method of normalization 
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can reduce statistical power by introducing unwanted variations or result in falsely discovered 
characteristics. 
The microbiome data can be treated as compositional because the information contained in the 
abundance tables is relative. In a microbiome abundance table, the total number of counts per 
sample is highly variable and is limited by the maximum number of DNA readings that can be 
provided by the sequencer (Calle, 2019). However, our low biomass tumor associated bacteria do 
not clearly follow this phenomenon, as the presence of bacteria is constrained, not by the 
sequencing depth, but by other factors as performance of purification techniques or the capture of 
the messenger RNAs, or maybe it is due to luck, or to contamination in a further step. So, we 
should review if this assumption is accomplished in tumor low biomass samples. 
It was decided not to carry out either of these two methods because compositional methodology 
requires zeros to be imputed rather than modelled, and with standardisation the zeros would be 
transformed. When applying regression models, such as the Zero Hurdle Model or Zero Inflated 
Models, these directly model and adjust them to a specific distribution, it is not necessary to either 
impute or transform them, and this was the main objective of the project: "the management of zero 
values".   
With these models I have demonstrated that the data present a clear over-dispersion, since they 
adjust much better to a Negative Binomial distribution than to a Poisson distribution and that they 
are better modelled with the Zero Hurdle Model, than when modelling on the one hand the positive 
counts and on the other hand the zeros (and that they are models that are not based on a distribution 
with a mass function concentrated on zero, like the Zero Inflated Model) work with low 
percentages of zeros. The fact that they are better modelled with the Zero Hurdle Negative 
Binomial model means that the three types of zeros defined by Kaul et al., in 2017, are in the 
Kraken Counts database. 
By analysing all possible situations with different percentages of zeros, it was shown that the Zero 
Hurdle Model works better than the other options regardless of the number of zeros the bacteria 
have, so the database was automated. Those bacteria without zeros were modelled with the GLM 
Negative Binomial and those with zeros, with the Zero Hurdle Negative Binomials Models (all 
these results are in the appendices), using as covariates the variables of Table 3. Previously, having 
eliminated the cases with a percentage < 99% of zeros. 
All articles, such as those by Chen, P et al (2018) study the behaviour of a single situation with a 
sufficient number of zeros to be able to declare it as excess zeros. None of these articles apply 
these models (neither the Zero Inflated Model nor the Zero Hurdle Model) to a large database, nor 
do they check what happens with those cases with "low" percentages of zeros. Therefore, 
demonstrating that ZHNB work perfectly was a great advantage when automating the database 
analysis. So, the workflow developed in Figure 6, would be updated to the next one (Figure 19): 
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Figure 19. Updated workflow for Figure 5. Note that any percentage of zeros is better modelled with a Zero Hurdle Model than 
with other models, the database is divided into two groups: bacteria that have zeros and bacteria without zeros. Those bacteria 
that have no zeros are modelled with a GLM, and those that have zeros are modelled with a Zero Hurdle Model. 
All the results obtained (applying the workflow developed in Graph 18) can be found by accessing 
the following QR code, which range from page one to page 425: 
 
 
 
 
One thing that needs to be pointed out is that these models can not only be applied to microbiome 
data, but they can be applied to any kind of omic count data with zeros, offering a very high 
projection and applicability. 
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In addition, in recent months, regression models for zero count data have become very important 
and have become more widely known, due to the global pandemic experienced during 2020. Many 
researchers have used these types of models to model CoVid-19 data in hospitals (Ilyas et al., 
2020) , nursing homes (Goldfeld, 2020), mortality (O Adepoju et al., 2020), etc.   
With this I would like to emphasize the great applicability that these models have and that it is not 
necessary to have a high percentage of zeros to be able to carry them out. The only condition that 
must be met is that they must be count data and that they must have zeros, so they can be carried 
out in any field of research. 
 
8. Future planes: 
 
This Project will continue to be developed during the coming months thanks to a grant from Center 
for Biomedical Research Network Cancer (CIBERONC) supported by Dr. Malats, Group Leader 
of the laboratory of Genetic and Molecular Epidemiology Group, of the National Cancer Research 
Center (CNIO). The project will also be co-directed by María Dolores Alonso, who in the same 
way that she has been supporting and accompanying me throughout the final master's thesis, will 
continue to do so during this grant. She will provide me with the biological and bioinformatics 
vision that I lack, and with which I have carried out multiple debates on the limitations of this type 
of data, making me understand that not only must a methodology be taken into account, but also 
the biological limitations of the data. It is a real pleasure for me to have been given this opportunity, 
and for such professional people to accompany me. 
A scientific article will be carried out describing the methodology used in this thesis and its 
biological impact, specifying which bacteria proved to be statistically significant and their effect 
on the different covariates. In addition, the standardization proposed by L. Chen et al. will be 
applied and it will be analysed if the data are better modelled with regression models for count 
data, or applying a previous standardization and adjusting it to a Gaussian distribution. 
A compositional methodology is also intended to be carried out, taking into account the biological 
limitations of these data. 
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1. Code applied throughout the final master's thesis: 
 
Throughout the work different methods have been exposed and various graphics have 
been explained, all created from the RStudio software. In this section, all the packages 
and functions that have been used will be shown, and all the steps that have been followed 
to carry out the project will be described: 
I. Load and adapt the database: as mentioned above, the database to be used is 
Kraken, so it is the first one to be loaded and adapted for future models. It is also 
shown how the Elbow and Silhouette method was carried out to obtain the optimal 
number of clusters and the k-means clustering. 
 
kraken <- read.delim("C:/Users/hfidalgo/Desktop/Dataset/kraken_coun
ts_sorted.tsv", row.names=1) 
data <- kraken[,1:433] 
dim(data) 
#Dertermining And Visualizing The Optimal Number Of Clusters: 
library(ggplot2) 
library(factoextra) 
set.seed(2119) 
elbow <- fviz_nbclust(Bacterias_en_filas, kmeans, method = "wss") + 
labs(subtitle = "Elbow method") 
silhoutte <- fviz_nbclust(data, kmeans, method = "silhouette",     
print.summary = TRUE) + labs(subtitle = "Silhouette method") 
print(silhoutte) 
optimal <- silhoutte$data 
print(optimal <- as.data.frame(optimal)) 
library(dplyr) 
optimal2 <- optimal %>% filter(y == max(y)); as.numeric(optimal2[,1
]) 
# Optimal2 contains the optimal number of clusters that have been ca
lculated with the Elbow and Silhouette method. Optimal2 is included 
in the "eclust" function to obtain the k-means clustering: 
library(NbClust) 
B.Kmeans <- eclust(data, FUNcluster = "kmeans", k= as.numeric(optim
al2[,1]), k.max = as.numeric(optimal2[,1]), stand = T, graph = T, h
c_metric = "euclidean", hc_method = "ward.D2", gap_maxSE = list(met
hods= "firstSEmax", SE.factor = 1), nboot = 100, verbose = TRUE, se
ed = 2119) 
fviz_silhouette(B.Kmeans) 
B.Kmeans$nbclust # Number of clusters calculated. 
table(B.Kmeans$cluster) 
nclust <- B.Kmeans$cluster  
typeof(nclust) 
nclust <- as.matrix(nclust) 
nclust <- as.data.frame(nclust)  
nclust <- rename(nclust, factor.cluster = V1) 
#This new column has been created, and it contains two different ca
tegories: 1 and 2. Bacteria belonging to cluster 1 have category 1 
and bacteria belonging to cluster 2 have category 2. This column is 
added to the kraken database, so that later on the database can be 
divided into two different groups: 
head(kraken) 
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head(nclust) 
kraken.f <- merge(kraken, nclust, by=0, all=TRUE) 
#We separate the databases according to the cluster they belong to: 
clst1 <- subset(kraken.f, factor.cluster=="1") 
head(clst1);dim(clst1) 
clst2 <- subset(kraken.f, factor.cluster=="2") 
head(clst2,29);dim(clst2) 
 
II. Loading of the following database and selection of variables: the next database to 
be used will be metadataBCLA_RNA, as explained at the beginning of section 5 
of the project (5. Application to a real database, page 22), only certain variables 
will be selected and the variable BMI will be imputed, using the function "mice" 
and as "predictive mean matching" methodology. 
metadataBLCA_RNA <- read.delim("C:/Users/hfidalgo/Desktop/Datasets/
metadataBLCA_RNA2019-02-20_TLRs_Thorsson_clinical_exposure.tsv") 
library(dplyr) 
library(tidyverse) 
library(tibble) 
# Selection of the numerical variables: 
metadata = metadataBLCA_RNA %>% select(File.Name,exprIL1B, exprTLR7
,exprNOD1, Leukocyte.Fraction,SNV.Neoantigens,bmi) 
metadata$File.Name <- gsub("_gdc_realn_rehead.bam", "", metadata$Fi
le.Name) 
has_rownames(metadata) 
metadata <- column_to_rownames(metadata, var = "File.Name") 
metadata = metadata[order(row.names(metadata)),] 
head(metadata) 
#For the BMI column: before imputing the variable BMI, the values “-
-" are replaced by missing values, then the imputation is carried ou
t using the predictive mean matching method (method = "pmm"). 
metadata$bmi <- as.character(metadata$bmi) 
metadata$bmi <- as.numeric(metadata$bmi) #the values "--" have been 
replaced by NA 
library(mice) 
metadata.imp <- mice(metadata, method = "pmm", seed=500) 
densityplot (metadata_final.imp, ~ bmi|.imp) 
metadata.imp <- complete(metadata.imp,1) 
View(metadata.imp) 
metadata$File.Name <- gsub("_gdc_realn_rehead.bam", "", metadata$Fi
le.Name) 
has_rownames(metadata) 
metadata <- column_to_rownames(metadata, var = "File.Name") 
#We order both databases, as both databases have the same subject ID
, which are found in the row.names, so that ordering both databases 
by subject ID is sufficient. 
metadata = metadata[order(row.names(metadata)),] 
metadata.imp = metadata.imp[order(row.names(metadata.imp)),] 
#We replace the original BMI variable by the imputed BMI variable    
(BMI.imp): 
metadata$bmi <- NULL 
metadata$bmi.imp <- metadata.imp$bmi 
# With the function "cut" the variable is categorized in: "Under", "
Normal", "Overweight" and "Obese". 
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metadata$bmi.imp <- cut(metadata$bmi.imp, breaks = c(min(metadata$b
mi.imp), 18.5, 25, 30, max(metadata$bmi.imp)), labels = c("Under", 
"Normal", "Overweight", "Obese")) 
table(metadata$bmi.imp) 
# The rest of the remaining variables are included: 
metadata$Immune.Subtype <- metadata$Immune.Subtype 
metadata$tumor_stage <- metadata$tumor_stage 
metadata$tumor_stage = levels(metadata_final$tumor_stage)[levels(me
tadata_final$tumor_stage)=="not reported"] <- NA 
 
III. Sort the clst1 and clst2 databases and eliminate those bacteria with more than 
99% of zeros: the databases that have been created in the first section are ordered, 
and the number of zeros in each one of them is also studied: those with 99% of 
zeros are eliminated from the database, since it is not possible to obtain reliable 
results with such a high percentage of zeros. 
 
#A. Clst1: 
library(tibble) 
library(dplyr) 
head(select(clst1, 1:5)) 
clst1 <- rename(clst1, tax.ID = Row.names) 
has_rownames(clst1) 
clst1 <- remove_rownames(clst1)  
clst1 <- column_to_rownames(clst1, var = "species")  
library(dplyr) 
clst1 <- clst1 %>%  
           select(-1, -(434:435)) 
clst1 <- as.data.frame(t(clst1)) 
rownames(clst1) <- sub("X", "", rownames(clst1)) 
head(clst1) 
 
#B. Clst2: 
clst2 <- rename(clst2, tax.ID = Row.names) 
has_rownames(clst2) 
clst2 <- remove_rownames(clst2)  
clst2 <- column_to_rownames(clst2, var = "species") 
library(dplyr) 
clst1 <- clst1 %>%  
           select(-1, -(434:435)) 
clst2 <- as.data.frame(t(clst2))  
head(clst2,8) 
rownames(clst2) <- sub("X", "", rownames(clst2)) 
 
# It is checked that bacteria are only 0:   
Especie_clst2 = unique(names(clst2)) 
for(i in 1:length(clst2)){ 
   n0 <-sum(clst2[[i]]=="0")  
   print(paste("Bacterium:",Especie_clst2[i] ,"has",n0,"zeros")) 
} 
# It is verified that 1602 bacteria present 433 zeros (which is the  
maximum that can contain), these bacteria cannot be modelled since  
no model would converge. The next step will be to eliminate from the 
"clst2" database those bacteria with more than 99% of zeros: 
clst2 = clst2[,colSums(clst2==0, na.rm=T)/nrow(clst2)<0.99] 
dim(clst2) 
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IV. Test the different models, apply model selection criteria, obtain the residuals and 
the Rootogram: this part of the code shows the packages and functions used to 
carry out the different models, as well as the creation of the offset, along with the 
different model selection criteria (AIC, BIC, Likelihood Ratio Test and Vuong 
Test), residuals and Rootogram. 
 
#1). Offset: 
totalReadsKraken <- read.delim("C:/Users/hfidalgo/Desktop/Bases de 
datos/totalReadsKraken.tsv") 
totalReadsKraken = totalReadsKraken[order(row.names(totalReadsKrake
n)),] 
clst2 = clst2[order(row.names(clst2)),] 
clst2$Offset <- log(totalReadsKraken$nonHumanReads) 
clst1 = clst1[order(row.names(clst1)),] 
clst1$Offset <- log(totalReadsKraken$nonHumanReads) 
 
#2). Formula:  
clst2 = clst2[order(row.names(clst2)),] 
clst1 = clst1[order(row.names(clst1)),] 
metadata = metadata[order(row.names(metadata)),] 
f1 <- formula(clst2$`Leuconostoc mesenteroides` ~ metadata$exprTLR7 
+ offset(clst2$Offset)|metadata $exprTLR7) 
# f1 would be the same as put:   
f2 <- formula(clst2$`Leuconostoc mesenteroides` ~ metadata$exprTLR7 
+ offset(clst2$Offset)) 
# Formula for "clst1": 
f3 <- formula(clst1$`Klebsiella pneumoniae` ~ metadata$exprTLR7+off
set(clst1$Offset)) 
 
#3). Models: 
library(MASS) 
library(pscl) 
library(gee) 
library(geepack) 
 #-> Zero Inflated Models: 
summary(ZIP <- zeroinfl(f1, dist = "poisson", link = "logit", data 
= metadata)) 
summary(ZINB <- zeroinfl(f1, dist = "negbin", link = "logit", data 
= metadata)) 
 #-> Zero Hurdle Models: 
summary(ZHP <- hurdle(formula = f1, dist= "negbin", data=metadata)) 
summary(ZHNB <- hurdle(formula = f1, dist= "negbin", data=metadata)
) 
 #-> GLM Models: 
summary(GLMP  <- glm(f3, family = "poisson" ,data = metadata)) 
summary(NB.model <- glm.nb(f3,data = metadata)) 
 
#4). Model Selection Criteria: 
library(lmtest) 
library(nonnest2) 
 #AIC and BIC criteria: 
icci(ZHP,ZHNB)  
 #Likelihood Ratio Test: 
lrtest(ZHP, ZHNB) 
 #Vuong Test: 
vuongtest(ZINB, ZHNB) 
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#5). QQ Plots:  
res <- resid(ZHNB, type = "pearson") 
qqnorm(res) 
qqline(res) 
 
#6). Rootogram: 
install.packages("countreg", repos="http://R-Forge.R-project.org")l
ibrary(countreg) 
rootogram(ZHNB, max = 100) # fit up to count 100 
 
V. Final Results: throughout the project it was shown that all those bacteria with at 
least 1 zero, fit much better to a Zero Hurdle Model than to a GLM. Therefore, 
two different models are applied to the Kraken database: bacteria without any zero 
fit a GLM negative binomial model and bacteria with at least 1 zero fit a Zero 
Hurdle Negative Binomial Model: 
 
#The Kraken database is divided into 2 groups, one containing bacte 
ria with zeros and one without zeros: 
kraken <- read.delim("C:/Users/hfidalgo/Desktop/Datasets/kraken_cou
nts_sorted.tsv", row.names=1) 
library(tibble) 
has_rownames(kraken) 
data <- remove_rownames(kraken)  
data <- column_to_rownames(data, var = "species") 
head(data) 
data <- data[,-434] 
data <- as.data.frame(t(data))  
head(data,8) 
rownames(data) <- sub("X", "", rownames(data))  
#Bacteria are eliminated with <99% zeros: 
data = data[,colSums(data==0, na.rm=T)/nrow(data)<0.99] 
dim(data) 
 
Bact.Nonzeros =  data[,colSums(data==0, na.rm=F)/nrow(data)<=0] 
head(Bact.Nonzeros); dim(Bact.Nonzeros)# contains 3 bacteria 
 
Bact.Zeros = data[,colSums(data==0, na.rm=T)/nrow(data)>0] 
head(Bact.Zeros); dim(Bact.Zeros)#contains 1605 bacteria 
 
#create the offset: 
totalReadsKraken <- read.delim("C:/Users/hfidalgo/Desktop/Bases de 
datos/totalReadsKraken.tsv") 
totalReadsKraken = totalReadsKraken[order(row.names(totalReadsKrake
n)),] 
Bact.Nonzeros = Bact.Nonzeros[order(row.names(Bact.Nonzeros)),] 
Bact.Nonzeros$Offset <- log(totalReadsKraken$nonHumanReads) 
 
Bact.Zeros = Bact.Zeros[order(row.names(Bact.Zeros)),] 
Bact.Zeros$Offset <- log(totalReadsKraken$nonHumanReads) 
 
#To carry out the models, the MetadataBCLA_RNA database is used, the 
steps explained in section II are carried out. 
Bact.Nonzeros = Bact.Nonzeros[order(row.names(Bact.Nonzeros)),] 
Bact.Zeros = Bact.Zeros[order(row.names(Bact.Zeros)),] 
metadata = metadata [order(row.names(metadata)),] 
#Final results for bacteria with zeros: 
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getOption("max.print") 
options(max.print=999999999) 
# run n regressions: 
dim(Bact.Zeros) 
n <- 1605 
my_lms <- lapply(1:n, function(x) hurdle(Bact.Zeros[,x] ~ metadata$
exprMAP3K7 + offset(Bact.Zeros$Offset),dist= "negbin" ,data = meta 
data)) 
fvn <- data.frame(iteration=seq(1,n),t(sapply(my_lms,coefficients))
) 
fvn <- column_to_rownames(fvn, var = "iteration") 
fvn <- as.data.frame(fvn) 
row.names(fvn) <- NULL 
Bact.Zeros$Offset <- NULL 
Especie = unique(names(Bact.Zeros)) 
for(i in 1:n){ 
  row.names(fvn)[i] <- Especie[i] 
} 
#A .txt document would be generated containing: count intercept, zer
o intercept,... 
write.table(fvn, "Bacteria + ExprMAP3k7.txt") 
#To download the p_values: 
pv_int_count <- c() 
pv_cov_count <- c() 
pv_int_zero <- c() 
pv_cov_zero <- c() 
for(i in seq(1,n, by=1)){  
 pv_int_count[[i]] = summary(my_lms[[i]])$coefficients$count[1,"                        
Pr(>|z|)"]; 
   pv <- as.data.frame(pv_int_count); 
   pv = (t(pv)); 
  pv_cov_count[[i]] = summary(my_lms[[i]])$coefficients$count[2,"
Pr(>|z|)"]; 
   pv2 <- as.data.frame(pv_cov_count); 
   pv2 = (t(pv2)); 
  pv_int_zero[[i]] = summary(my_lms[[i]])$coefficients$zero[1,"Pr
(>|z|)"]; 
   pv3 <- as.data.frame(pv_int_zero); 
   pv3 = (t(pv3)); 
 pv_cov_zero[[i]] = summary(my_lms[[i]])$coefficients$zero[2,"Pr
(>|z|)"]; 
   pv4 <- as.data.frame(pv_cov_zero); 
   pv4 = (t(pv4)); 
} 
write.table(cbind(pv,pv2,pv3,pv4),file="Pvalues-Bacteria + ExprMAP3
k7.txt",row.names=F, col.names=c('Pv.Inter_count','Pv.Cov_count','P
v.Inter_zero','Pv.Cov_zero')) 
 
 
#Final results for bacteria without zeros: 
getOption("max.print") 
options(max.print=999999999) 
# run n regressions: 
dim(Bact.Nonzeros) 
n <- 3 
my_lms <- lapply(1:n, function(x) glm.nb(Bact.Nonzeros[,x] ~ metada
ta $gender + offset(Bact.Nonzeros$Offset), data = metadata)) 
fvn <- data.frame(iteration=seq(1,n),t(sapply(my_lms,coefficients))
) 
fvn <- column_to_rownames(fvn, var = "iteration") 
fvn <- as.data.frame(fvn) 
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row.names(fvn) <- NULL 
Bact.Nonzeros$Offset <- NULL 
Especie = unique(names(Bact.Nonzeros)) 
for(i in 1:n){ 
  row.names(fvn)[i] <- Especie[i] 
} 
write.table(fvn, "Bacteria without zeros + Gender.txt") 
p_values <- c() 
for(i in seq(1,n, by=1)){  
 p_values[[i]]=summary(my_lms[[i]])$coefficients[,"Pr(>|z|)"]; 
 pv <- as.data.frame(p_values); 
 pv = (t(pv)) 
} 
write.table(pv,file="Pvalues-Bacteria without zeros + Gender.txt", 
row.names=F, col.names=c('Pv.Intercept','Pv.Covariable')) 
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2. Summary table of MetadataBCLA_RNA database: 
Table showing the percentage of missing values in total, the median, the variance and the 
interquartile range of each variable: 
exprCHUK -0.389 1.113 1.281
exprCXCL8 -0.415 1.330 0.537
exprIFNA1 -0.405 0.434 0.253
exprIFNB1 -0.244 1.435 0.164
exprIFNG -0.346 0.669 0.221
exprIKBKB -0.280 1.351 1.412
exprIKBKG -0.208 1.693 1.285
exprIL12A -0.189 0.876 0.203
exprIL12B -0.321 0.839 0.476
exprIL1B -0.339 4.068 0.551
exprIL6 -0.210 1.041 0.195
exprIRAK1 -0.325 1.271 1.329
exprIRAK4 -0.061 1.718 1.401
exprMAP3K7 -0.458 1.605 1.353
exprMDK -0.306 0.944 1.051
exprMYD88 -0.149 1.729 1.341
exprNOD1 0.008 1.884 0.862
exprNOD2 -0.371 0.850 0.557
exprSLC15A1 -0.361 1.342 0.672
exprTAB2 -0.214 1.012 1.280
exprTLR1 -0.333 0.768 0.699
exprTLR10 -0.224 0.645 0.087
exprTLR2 -0.366 0.998 0.805
exprTLR3 -0.436 0.787 0.806
exprTLR4 -0.416 0.636 0.738
exprTLR5 -0.237 1.540 1.027
exprTLR6 -0.422 0.854 0.684
exprTLR7 -0.336 5.719 0.659
exprTLR8 -0.434 0.923 0.531
exprTLR9 -0.272 0.516 0.302
exprTNF -0.237 1.253 0.193
exprTRAF3 -0.322 1.022 1.307
exprTRAF6 -0.411 1.858 1.395
Immune Subtype C2 - -
TCGA Subtype BLCA.2 - -
Leukocyte Fraction 0.202 0.027 0.233
Stromal Fraction 0.4 0.050 0.371
Intratumor 
Heterogeneity
 0.16 0.032 0.2512.540
4.389
4.389
3.233
65.589
0
2.540
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
4.389
Variable
Percentage of missing 
values (%NA)
Median Var IQR
4.389
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TIL Regional 
Fraction
4.967 42.778 7.139
Proliferation  0.558 0.274 0.595
Wound Healing  0.184 0.027 0.228
Macrophage 
Regulation
-0.3997 0.729 1.243
Lymphocyte 
Infiltration 
-18641 1.508 1.751
IFN-gamma 
Response
 0.1190 0.977 1.462
TGF-beta Response  0.0841 0.196 0.666
SNV Neoantigens 72 15113.706 96.751
Indel Neoantigens 29.5 5941.0518 73
Silent Mutation Rate 1.587 6.449 1.901
Nonsilent Mutation 
Rate
4.613 55.896 5.834
Number of Segments 168 15462.210 151
Fraction Altered 0.554 0.078 0.449
Aneuploidy Score 13 46.547 11
Homologous 
Recombination 
Defects
 27 281.128 24
BCR Evenness 0.884 0.017 0.124
BCR Shannon 1.908 1.654 2.231
BCR Richness   9 1555.325 31
TCR Shannon 1.946 1.281 1.657
TCR Richness   5 370.366 13
TCR Evenness 0.981 0.002 0.042
CTA Score 2.869 2.537 2.771
Th1 Cells -2376.544 735484.035 1143.974
Th2 Cells   447.678 307870.849 707.381
Th17 Cells -3013.005 2527519.993 2273.981
B Cells Memory 0.020 0.005 0.074
B Cells Naive 0.002 0.004 0.040
Dendritic Cells 
Activated
0.026 0.004 0.068
Dendritic Cells 
Resting
0.003 0.001 0.021
Eosinophils 0 5.016e-05 0
Macrophages M0 0.0178 0.009 0.093
Macrophages M1 0.032 0.003 0.076
Macrophages M2 0.203 0.014 0.155
Mast Cells Activated 0 0.002 0.041
Mast Cells Resting 0.014 0.003 0.057
Monocytes 0.018 0.001 0.028
Neutrophils 0 0.001 0.006
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
36.027
16.628
3.233
24.942
3.695
3.233
0.924
0.924
2.309
2.309
46.189
36.027
3.233
3.233
0.693
8.083
1.616
1.616
26.097
3.233
3.233
3.233
3.233
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NK Cells Activated 0.025 0.001 0.047
NK Cells Resting 0.001 0.001 0.030
Plasma Cells 0.030 0.004 0.066
T Cells CD4 
Memory Activated
0 0.001 0.005
T Cells CD4 
Memory Resting
0.012 0.003 0.077
T Cells CD4 Naive 0 0.005 0.020
T Cells CD8 0.109 0.007 0.104
T Cells Follicular 
Helper
0.0839 0.004 0.074
T Cells gamma delta 0 2.209e-05 0
T Cells Regulatory 
Tregs
0.015 0.001 0.035
Lymphocytes 0.521 0.023 0.218
Mast Cells 0.048 0.003 0.060
Dendritic Cells 0.042 0.005 0.075
Macrophages 0.348 0.023 0.189
OS 0 0.248 1
OS Time bdf 668320.422 581.250
PFI 0 0.246 1
PFI Time  423 595954.594 562
gender male - -
year_of_birth 1940 120.598 16
race white - -
ethnicity not hispanic or latino - -
year_of_death 2011 7.138 4
primary_diagnosis
Transitional cell 
carcinoma
- -
tumor_stage stage iii - -
age_at_diagnosis 25297 14975714.935 5728.510
vital_status alive - -
morphology 8120/3 - -
days_to_death  393 - -
tissue_or_organ_of_
origin
Bladder, NOS - -
days_to_birth -25297 - -
site_of_resection_or
_biopsy
Bladder, NOS - -
days_to_last_follow
_up
232 - -
cigarettes_per_day 0.548 7.961 1.589
weight 65 549.958 26.925
bmi 24.920 41.342 6.643
height 170 106.576 14
0
14.319
0
0
0
0
0
0
0
0
0
0
0
0
0
3.233
3.233
0
0
0
0
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
3.233
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3. Imputation of the BMI variable: 
 
As can be seen in the table above, the variable BMI presents 14.32% of missing values, 
therefore, an imputation of this variable will be carried out and later its categorizat ion: 
Underweight (BMI is less than 18.5) - Normal weight (BMI is 18.5 to 24.9) - Overweight 
(BMI is 25 to 29.9) - Obese (BMI ≥ 30). 
The two methods proposed to carry out the imputation are within the "mice"  package of 
RStudio software, they are (1) predictive mean matching ("pmm") and (2) Bayesian linear 
regression ("norm").  These two methods are recommended when working with 
continuous numerical data:  
1) Quality of the Imputations with predictive mean matching: 
With the "stripplot"  function, the distributions of the variables are shown as individua l 
points, the imputed data is shown in purple and the observed data in blue (Figure 1). 
 
 
 
 
 
 
 
 
With the "densityplot” function, the density of the imputed data is shown, the density for 
each imputed data set is shown in purple, while the density of the observed data is shown 
in blue (Figure 2). 
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2) Quality of imputations with Bayesian linear regression: 
With the "stripplot"  function (Figure 3): 
 
 
 
 
 
 
 
 
With the "densityplot"  function (Figure 4): 
 
 
 
 
 
 
 
As can be seen, the best results are obtained with the "predictive mean matching" method, 
so this is the method that will be used to carry out the imputation of the BMI variable. 
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4. Model outputs: 
 
4.1. Output 1: Zero Inflated Poisson model, using Streptococcus parauberis 
bacterium and Leukocyte Fraction as covariate: 
 
 
Output 1 
 
4.2. Output 2: Zero Inflated Negative Binomial model, using Streptococcus 
parauberis bacterium and Leukocyte Fraction as covariate: 
 
 
Output 2 
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4.3. Output 3: Zero Hurdle Poisson Model, using Streptococcus parauberis 
bacterium and Leukocyte Fraction as covariate: 
 
Output 3 
 
4.4. Output 4: Zero Hurdle Negative Binomial Model, using Streptococcus 
parauberis bacterium and Leukocyte Fraction as covariate: 
 
Output 4 
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4.5. Output 9: Zero Hurdle Negative Binomial model, using Streptococcus mitis 
bacterium and Tumor Stage as covariate: 
Output 9 
 
4.6. Output 13: DESeq2 output, using the bacteria without excess zeros and without 
zeros, and as a covariate, the two-level categorical variable: Sample type, 
Output 12 
 
 
 
